Cardiology Department

What the cardiology unit covers, and how the work is organised

Most people arrive at a cardiology clinic holding a piece of paper they cannot read. An ECG printed at a workplace medical, with the word abnormal somewhere near the top and no explanation underneath it. An echo report full of phrases like mild mitral regurgitation and grade 1 diastolic dysfunction. A calcium score from a scan someone talked them into at a screening centre. A cholesterol panel with two figures printed in red. Often there are no symptoms at all — only the paper, and a week of reading the internet at two in the morning.

The first thing worth saying is that a result is a signal, not a diagnosis. It tells a cardiologist where to look. It does not, on its own, tell you what you have or what will happen to you. Plenty of the phrases that frighten people on a report describe normal variation in a healthy heart, and a fair number of serious problems produce a report that reads as entirely unremarkable. Working out which of those two situations you are in is most of what a cardiology consultation actually does.

The other common way in is symptom-first: chest tightness when you walk uphill, a heart that thumps or races for no reason, breathlessness that has crept up over a few months, ankle swelling by the evening, or a blackout that nobody has explained. Those are different problems from an unexplained number, and they take a different path through the department.

Cardiology is the medical speciality that looks after the heart and its arteries, rhythms, valves and pumping function. Its work is diagnostic, medical, and — increasingly — done through a catheter: a narrow tube passed from the wrist or groin, through which arteries can be opened, valves replaced, faulty electrical circuits treated and holes closed, without opening the chest.

The work divides into six strands. Nearly every referral belongs to one of them, and knowing which one yours falls into tells you most of what to expect.

• Diagnosis and testing — the largest part of the department by volume, and the part most readers need first. It runs from the tests that record electrical activity, through the tests that image the heart, to the tests that look directly at the coronary arteries. The detail sits in ECG explained, echocardiogram, echo versus ECG, Holter and other monitors, stress testing, calcium score and CT coronary angiography. The order in which these are used is not random: each answers a different question, and the wrong test in the right patient produces a confident answer to a question nobody asked.
• Coronary artery disease — the furring and narrowing of the arteries that supply the heart muscle itself. This covers the symptom that brings most people in, the emergency that everyone fears, and the catheter procedures used to open a narrowed artery. It is dealt with in chest pain and angina, heart attack and coronary angiography and stents, and it connects directly to the risk-factor work in the prevention strand.
• Heart rhythm — everything from the extra beat that makes you cough at night to a heart that runs at twice its proper speed for hours. Electrophysiology is the sub-speciality that maps and treats these circuits from inside the heart, and it also implants the devices that pace a heart that is too slow or shock one that becomes dangerously fast. The strand covers palpitations, atrial fibrillation, ablation, stroke prevention in AF, pacemakers and ICDs and other arrhythmias.
• Valve and structural heart disease — leaking or narrowed valves, and the holes and appendages that can now be dealt with through a catheter rather than through the chest wall. Many people enter this strand because a doctor heard a murmur, or because an echo done for another reason found something. It runs through heart valve disease, aortic stenosis and TAVI, mitral regurgitation and structural heart closures.
• Heart failure and cardiomyopathy — the syndrome that results when the heart cannot meet the body’s demands, and the diseases of the heart muscle itself that sometimes cause it. The name is one of the worst in medicine, because it suggests an organ that has stopped working rather than one that is working under strain, and much of the consultation is spent undoing that impression. See heart failure, cardiomyopathy and ejection fraction, which is where the pumping figures on your report are explained.
• Prevention, blood pressure and lipids — the least dramatic strand and the one that alters the most lives. It covers the numbers that describe risk rather than disease, the arguments about what those numbers mean, and what is reasonable to do about them at different ages. See cholesterol and lipids, blood pressure and prevention and screening. Where a broader assessment is wanted rather than a single cardiac question, it overlaps with the check-up unit.

One boundary is worth stating plainly at the start, because it decides which pages are useful to you. Open-heart surgery is a separate unit. Coronary artery bypass grafting, surgical replacement or repair of a valve, surgery on the aorta and heart transplantation are performed by cardiovascular surgery, and they are described there rather than in the sections that follow. Where a decision genuinely sits between a catheter procedure and an operation — a heavily calcified valve, disease in several arteries at once — it is not made by either speciality alone. It goes to a heart team meeting where cardiologists, surgeons and imaging specialists look at the same images together and weigh the two routes against your age, your other conditions and what you want. When you are told a case will be discussed, that is what is meant.

Cardiology also works constantly across departmental lines: with neurology when a stroke may have come from the heart, with radiology and nuclear medicine for imaging, with endocrinology for diabetes and thyroid disease, and with dietetics for the parts of treatment that are not prescriptions. Those crossings are noted in the relevant sections rather than treated separately.

Emergency red flags

• Suspected heart attack. Chest pain, pressure, tightness or a crushing heaviness lasting more than a few minutes — or chest discomfort of any length that comes with sweating, nausea or vomiting, breathlessness, light-headedness, or pain spreading to one or both arms, the jaw, the neck, the back or the upper abdomen. It does not have to be severe, and it does not have to be on the left.
• Suspected stroke. Use FAST. Face — has one side of the face dropped, is the smile uneven. Arms — can both arms be raised and held up, or does one drift down. Speech — is speech slurred, jumbled, or absent, and can they understand you. Time — any one of these, present even briefly and even if it has already improved, is a stroke emergency. Sudden loss of vision in one eye, sudden severe unsteadiness, or the worst headache of your life fall into the same category. Stroke belongs to neurology, but it appears in a cardiology section because an irregular heart rhythm is one of its common sources.
• Fainting during exertion. Losing consciousness while running, climbing stairs, lifting or swimming is not the same as fainting in a hot room, at the sight of blood, or on standing up quickly. Blacking out at the moment the heart is being asked to work hardest points at the heart itself. It is routinely dismissed as heat, dehydration or missed meals, and that dismissal is the mistake. It also includes fainting with no warning at all, and fainting that follows palpitations.
• A shock from an implanted defibrillator. A single shock in someone who feels entirely well afterwards is treated differently from repeated shocks, but you are not the person who can make that distinction at home. A device that has fired is felt as a sudden hard thump in the chest, often described as being kicked or struck.
• Sustained fast palpitations with chest pain, breathlessness or near-fainting. A racing heart on its own is usually not an emergency. A racing heart that will not stop and is accompanied by chest pain, real breathlessness, greying vision or the feeling that you are about to go down is a different matter, because it means the rhythm is affecting the circulation rather than merely being unpleasant.
• Sudden severe tearing chest or back pain. Pain that arrives at maximum intensity in an instant, often described as ripping or tearing, often felt between the shoulder blades and sometimes moving downwards, can indicate a tear in the wall of the aorta. It may come with collapse, a weak pulse in one arm, or sudden weakness in a leg.

One warning that matters more than any other in this section: a heart attack does not always announce itself with crushing central chest pain. Women, people with diabetes, and adults over about seventy-five are considerably more likely to present without it. What appears instead may be sudden breathlessness with no chest pain at all, profound and unusual fatigue, nausea or indigestion-like discomfort, pain confined to the jaw, neck, back or between the shoulder blades, cold sweating, or simply a strong sense that something is badly wrong. In diabetes, nerve involvement can blunt the pain signal entirely, so the warning arrives as breathlessness or collapse.

ECG explained: what an EKG shows, and what it cannot

An ECG — written EKG in much of the world, from the German Elektrokardiogramm, and meaning exactly the same test — records the electrical activity that makes the heart contract. Ten electrodes are stuck to the chest, arms and legs; the machine reads the voltage differences between them and prints twelve views, or leads, of the same electrical event seen from twelve different angles. Nothing enters the body, nothing is injected, and no radiation is involved. The machine only listens. You feel the cold of the gel and, on removal, the tug of the adhesive.

What the trace can show is genuinely useful: the heart rate, whether the rhythm is regular and where it is being driven from, whether the electrical impulse is being delayed or blocked as it travels through the chambers, the electrical footprint of a heart attack that happened years ago, the acute changes of one happening now, indirect signs of a thickened or strained chamber, and disturbances caused by electrolyte abnormalities or by certain medications.

Now the part that is most misunderstood, and it is worth reading twice: a normal ECG does not exclude coronary artery disease. A resting ECG is a snapshot lasting about ten seconds. If a coronary artery is narrowed but the heart muscle is receiving enough blood while you lie still on a couch, the trace can be completely normal — even with severe narrowing. Someone with classic exertional angina and significantly diseased arteries very commonly has a normal resting ECG. The same limitation applies to rhythm: if your palpitations happen twice a week, the odds of the ten seconds of recording landing on one of them are poor, and a normal trace tells you only that your rhythm was normal during those ten seconds. This is precisely why the department also uses stress testing and ambulatory monitors — not because the first ECG was done badly, but because a resting snapshot cannot answer questions about what happens when you exert yourself or about events that come and go.

The second thing worth knowing concerns the words printed across the top of the paper. Almost every modern ECG machine prints an automated interpretation, generated by software from the shape of the waveform. It is a screening aid, and it is wrong often enough that no clinician treats it as a finding. It over-calls: it labels normal variants as abnormal, calls a perfectly healthy young athlete’s trace “abnormal ECG”, suggests old infarcts that never happened, and flags borderline measurements. It also occasionally under-calls something that matters. The word abnormal at the top of your printout is a machine’s opinion, and it is not a diagnosis. Only a clinician reading the actual waveform can say what it means for you.

The single most valuable thing you can bring to an ECG appointment is an older one. Much of ECG interpretation is comparison. A bundle branch block that has been present unchanged for a decade is a very different thing from one that appeared this month; T-wave changes that look identical to those from five years ago are far less concerning than new ones. If you have any previous tracing — in a discharge letter, a folder from a workplace medical, a photograph on your phone — take it. It changes conclusions more often than any additional test.

Words on your ECG report, in plain English

• Sinus rhythm. The normal rhythm. It means the heartbeat is being started by the sinus node, the heart’s own pacemaker, and travelling the usual route. “Normal sinus rhythm” is the phrase you want. Sinus tachycardia means the same rhythm running fast, which is what a normal heart does when you are anxious, in pain, unwell, dehydrated or have just climbed the stairs to the clinic. Sinus bradycardia means the same rhythm running slow, which is normal during sleep and common in fit people.
• Sinus arrhythmia. A rhythm that speeds slightly on breathing in and slows on breathing out. Despite the alarming name, this is a normal finding, particularly in children and young adults, and is generally a sign of healthy nervous control of the heart rather than of disease.
• Ectopic beats (also written APCs, PACs, VPCs, PVCs, or “extrasystoles”). Extra beats arriving early, from the upper chambers (atrial) or the lower chambers (ventricular). Nearly everybody has them; they become noticeable as a skipped beat, a thump, or a flutter in the throat. Occasional ectopics in a structurally normal heart are usually harmless. They are looked at more carefully when they are very frequent, when they come in runs, when they occur during exertion, or when there is other heart disease — which is where palpitations takes over.
• Right bundle branch block (RBBB). The electrical impulse travels down the left side of the conduction system normally but is delayed down the right, so the right ventricle contracts a fraction late. It is a common finding in healthy people, it is often present for life, and on its own in someone without symptoms it usually needs nothing beyond noting that it is there. It matters mainly because it changes how the rest of the trace must be read, and because a new one in the context of chest pain or breathlessness has to be explained.
• Left bundle branch block (LBBB). The mirror image, and taken considerably more seriously. Left bundle branch block is more often associated with underlying disease of the heart muscle, the valves or the coronary arteries, and it masks many of the ECG changes normally used to diagnose a heart attack — which is why a new LBBB in someone with chest pain is treated as a potential emergency in its own right. An LBBB found incidentally in a person without symptoms is not an emergency, but it is a reason for an echocardiogram to look at the heart muscle and valves rather than something to leave unexplained.
• Non-specific ST-T changes (or “non-specific ST-T wave abnormalities”). The most common frightening phrase on any report, and the least informative. It means the segment of the trace that follows each beat does not look textbook-normal, and the pattern does not match any particular diagnosis. Causes include body position, being female, anxiety, a recent meal, hyperventilation, electrolyte levels, medications, thickened heart muscle and — sometimes — reduced blood supply. In isolation, in someone without symptoms, it usually does not indicate disease. It is interpreted alongside your symptoms, your risk factors and, above all, your previous tracing.
• Early repolarisation. An upward shift where the ST segment begins, classically seen in young, fit, often male individuals. For most of the last century it was described as a benign normal variant, and in the overwhelming majority of people that remains the correct reading. It is looked at more carefully only when it appears in specific leads together with fainting or a family history of sudden death, which is a question for an assessment rather than for a search engine.
• Left axis deviation. A description of the overall direction the electrical impulse travels through the heart, tilted further to the left than average. It can be a normal variant, and it is more common with age, with a raised diaphragm, in overweight people and in those with a conduction delay. On its own it is a geometrical observation, not a disease.
• LVH by voltage criteria (left ventricular hypertrophy). The machine has measured tall waveforms and concluded that the muscle of the main pumping chamber may be thickened. Voltage criteria are notoriously unreliable: thin people, young people and athletes routinely trip them with entirely normal hearts, and heavier people with genuinely thickened muscle can fail to trip them at all. An ECG cannot measure wall thickness — the test that can is the echocardiogram, which measures it directly in millimetres. If your report says LVH by voltage criteria, the honest reading is “this needs an echo to confirm or dismiss”, and it is a common reason to check blood pressure properly.
• Prolonged QT (long QT, prolonged QTc). The QT interval measures how long the ventricles take to reset electrically after each beat, and it is corrected for heart rate — the “c” in QTc. When it is prolonged, the heart is theoretically more vulnerable to a dangerous rhythm, particularly if it becomes markedly prolonged. Some people inherit it. Far more commonly it is acquired: a low potassium or magnesium level, an underactive thyroid, or, most often of all, a medication. A long list of ordinary drugs lengthens the QT interval — certain antibiotics, antifungals, anti-nausea drugs, antidepressants, antipsychotics and some heart rhythm medicines among them — and the effect can add up when two are taken together. This matters, so it is worth being exact about what to do with it: take the report and a complete list of everything you take, including anything bought without a prescription, to the doctor who prescribed it. Do not stop or alter any medication yourself on the strength of an ECG printout. Deciding whether a drug is the cause, whether it can be changed, and what to check in the blood is a prescriber’s job, and stopping the wrong one can cause more harm than the QT interval itself.

Two closing points. First, an ECG is cheap, quick and harmless, which is why it is done so freely — and why so many people end up holding one with a strange phrase on it and no context. The context is the whole value. Second, if your ECG was reported as abnormal and nobody has explained it to you, ask for the trace itself rather than only the summary line. The printed waveform is the evidence; the summary is one reading of it.

Bundle branch block: right, left, and what a new one means

Picture the wiring as a trunk cable that leaves the upper chambers and divides into a right branch and a left branch, one for each pumping chamber. Bundle branch block means one branch has stopped conducting: the impulse still arrives, but by a slower detour through muscle, so one ventricle contracts a fraction after the other. The word describes electricity, not plumbing — nothing is obstructed and no blood is blocked.

Right bundle branch block is found in people with entirely normal hearts, becomes commoner with age, and is often lifelong and unchanging. Without symptoms or other findings it usually needs no treatment and no restriction, only recording, so the next reader knows it was already there. It matters mainly because it changes the shape of the rest of the trace, which must be interpreted around it.

Left bundle branch block is treated with more respect. The left branch is broad and well supplied, so losing it more often means the heart muscle, a valve or the coronary arteries have been affected, and LBBB is sometimes the first hint of a condition not yet diagnosed. One point outweighs the rest: LBBB masks the ECG changes normally used to diagnose a heart attack. Its pattern sits on top of the trace, so the usual signs cannot be read from it. That is why a new LBBB with chest pain is handled as a heart attack until proven otherwise.

Everything turns on old versus new, which is what a previous tracing settles. A block documented years ago and unchanged is a known feature of your heart; the same pattern appearing for the first time needs an explanation, and where there are no acute symptoms that explanation usually begins with an echocardiogram, to see whether the muscle and valves are normal behind it.

Conduction delay reaches devices by two separate routes. A bundle branch block alone is not a reason for a pacemaker; blocks between the upper and lower chambers are the ones that lead there, under bradycardia and heart block. Separately, a long-standing left bundle branch block can leave the walls of a weakened heart contracting out of step, and re-coordinating them is the purpose of the resynchronisation pacing described in pacemakers and ICDs.

Echocardiogram: what the scan shows and what the cost depends on

An echocardiogram is an ultrasound scan of the heart. It is the single most useful test in cardiology, and it does something no ECG can do: it shows the heart as a moving picture. Sound waves are sent from a probe held against the chest, bounce off the structures inside, and are converted into live images of the chambers contracting, the valves opening and closing, and the blood moving through them. There is no radiation and nothing is passed into the body for a standard scan. Practically, you undress to the waist, wear a gown, lie on your left side with your left arm up behind your head, and a sonographer or cardiologist presses a warm, gel-covered probe into the spaces between your ribs and just under the breastbone. The pressure can be uncomfortable, particularly under the ribs, and you will be asked to hold your breath at various points. A few ECG stickers are usually applied at the same time, so that each image can be tied to the point in the cardiac cycle it belongs to.

There are two main forms. A transthoracic echocardiogram (TTE) is the standard scan described above, done from the outside of the chest, and it answers the great majority of questions. A transoesophageal echocardiogram (TOE, TEE in American usage) uses a much smaller probe swallowed into the oesophagus, which sits directly behind the heart. It is done when the view from outside is not good enough or when the question demands very fine detail: assessing a mitral valve before repair, examining a replacement valve, looking for infection on a valve, hunting for a clot in the left atrial appendage before a cardioversion or an ablation, or searching for a hole between the upper chambers. You fast beforehand, your throat is numbed with a spray, and sedation is usually given, so you will need someone to take you home and you should not drive that day. It is more invasive than a TTE and carries real, if uncommon, risks: gagging and a sore throat afterwards are usual; the sedation itself carries the risks of any sedation, particularly in people with sleep apnoea or lung disease; and injury to the oesophagus is rare but recognised, which is why a history of swallowing problems or oesophageal disease must be declared beforehand.

What the scan measures, in outline: the size of each of the four chambers; the thickness of the heart muscle walls; how the walls move, both overall and region by region, since a segment that moves poorly can indicate an artery problem in the territory that supplies it; the structure and function of all four valves, including how much they leak and how freely they open; blood flow velocities, from which pressures inside the heart and in the lungs’ arteries can be estimated; the sac around the heart and any fluid within it; and the first part of the aorta. It also measures how strongly the main pumping chamber empties with each beat — the measurement that generates more anxiety than any other on a cardiac report. That number has its own section: see ejection fraction, where what the figures mean is set out properly.

An echo can also be combined with exertion or with a drug that makes the heart work harder, producing a stress echo, which asks a different question — whether any part of the muscle stops moving properly under load. That belongs to stress testing. In some people, particularly those with a large body habitus or significant lung disease, the images from outside are simply poor. A contrast agent made of tiny gas-filled microbubbles can then be injected through a vein to outline the inner border of the chamber more clearly; allergic reactions to it are rare but possible, and you will be asked about previous reactions first.

Words on your echo report

• Trace, mild, moderate or severe regurgitation. Regurgitation means a valve leaks backwards a little when it should be shut. The grading matters far more than the word. Trace and trivial regurgitation of the mitral, tricuspid or pulmonary valves is found in a very large proportion of completely normal hearts — modern ultrasound is sensitive enough to detect a few backward-moving red cells, and detecting them is not the same as finding disease. Mild regurgitation is usually also a finding rather than a condition, commonly noted and commonly stable for decades. Moderate earns an interval scan and a look at why it is there. Severe is the level at which the leak may be loading the heart and at which treatment enters the conversation. Trace and mild findings do not need treatment, do not need activity restriction, and do not, on their own, mean you have “a heart valve problem” in the sense you are imagining. See heart valve disease.
• Sclerosis versus stenosis. These two words look alike and mean quite different things. Aortic sclerosis means the valve leaflets have thickened or calcified with age but still open normally — the valve is not obstructing anything. Aortic stenosis means the valve has actually become narrowed, so the heart must generate more pressure to push blood through it. Sclerosis is very common with age and is followed rather than treated, though it is a marker worth noting because a minority progresses. Stenosis is graded and monitored, and at the severe end it is the condition dealt with in aortic stenosis and TAVI.
• Diastolic dysfunction, grade 1 / 2 / 3. This describes filling rather than pumping — how easily the main chamber relaxes and fills between beats. Grade 1, impaired relaxation, is extremely common: it increases with age, with long-standing high blood pressure and with thickened muscle, and in an older person without symptoms it is frequently reported as a normal finding for their age rather than a disease. Grade 2 and grade 3 indicate progressively raised filling pressures and are taken more seriously, particularly when there is breathlessness, because this is the mechanism behind heart failure with a preserved pumping measurement. See heart failure.
• Pericardial effusion. Fluid in the sac surrounding the heart. Small effusions are frequently incidental, follow a viral illness or an operation, and resolve or remain stable. What matters is not only the volume but whether the fluid is pressing on the heart and restricting its filling — the report may comment on this directly. A small effusion with no compression is watched; a large or compressing one is dealt with urgently.
• LVH (left ventricular hypertrophy). Here, unlike on an ECG, this is a direct measurement: the muscle wall of the main pumping chamber is thicker than expected. The usual cause by a wide margin is high blood pressure, working the muscle harder for years — which makes an echo report of LVH a strong reason to have blood pressure properly assessed. Other causes include aortic stenosis, athletic training and inherited diseases of the heart muscle, which are covered in cardiomyopathy.

On echocardiogram cost, the honest answer is that there is no single figure, and any source quoting one to you is describing a different situation from yours. What actually determines the price: whether the study is a standard transthoracic scan or a transoesophageal one, since the latter involves sedation, a recovery period and additional staff; whether it is a plain resting echo or a stress echo, which takes far longer and requires a physician present throughout; whether contrast is used; whether the scan is a standalone booking or bundled inside a cardiology consultation that also includes an ECG and a clinical review; whether it is a first diagnostic study or a short surveillance scan repeating a single measurement; and whether the quoted figure includes the images, the formal written report, and a follow-up appointment to explain them. Two “echocardiograms” can therefore be quite different products.

So ask for the figure that applies to you, in writing, before you book, and ask it as a specific question: which type of scan is being quoted, whether the consultation and report are included, and whether anything commonly added — contrast, a stress protocol, a repeat scan — would be charged separately. Ask also what you receive afterwards. You should expect the images themselves, not only a letter. The report is one person’s summary of one study on one day; the images are the evidence, and they are what any later opinion will need.

Echo vs EKG: what is the difference

An ECG records the heart’s electrical activity; an echocardiogram shows the heart’s structure and movement. That is the whole difference, and everything else follows from it. One reads the wiring, the other watches the pump. They are not versions of the same test, one basic and one advanced, and having had a normal ECG is not a reason to skip an echo — or the reverse.

Test	What it measures	What it shows well	What it misses	How long it takes	What it feels like
ECG (EKG)	Electrical activity, read from electrodes on the skin: rate, rhythm, and how the impulse travels through the chambers.	The rhythm at that moment, conduction problems such as bundle branch block, the electrical scar of an old heart attack, the acute changes of one in progress, and clues to electrolyte or drug effects.	Structure. It cannot show a valve, a chamber size or how well the heart pumps. It also misses anything intermittent, and a normal trace does not exclude coronary artery disease.	Minutes, most of it spent applying and removing the stickers.	Stickers on the chest, arms and legs. You lie still and breathe normally. Nothing enters the body; the adhesive tugs on removal.
Echocardiogram	Structure and motion, using ultrasound: chamber sizes, wall thickness and movement, valve function, blood flow, estimated pressures, and the sac around the heart.	Valve disease, the pumping measurement, thickened or dilated chambers, fluid around the heart, congenital abnormalities, and most cardiac causes of a murmur or of breathlessness.	Rhythm over time — it sees only the beats occurring during the scan. It does not image the coronary arteries themselves and does not exclude coronary artery disease. Image quality can be limited by body habitus or lung disease.	Usually around half an hour; longer if extra views, contrast or a stress protocol are added.	You lie on your left side in a gown, warm gel on the chest, firm probe pressure between the ribs and under the breastbone, with breath-holds. Uncomfortable in places rather than painful.

They are so often ordered together because each covers the other’s blind spot, and because the pairing frequently changes the interpretation of both. An ECG showing possible thickening is confirmed or dismissed by an echo that measures the wall directly. An echo showing a dilated left atrium raises the question of an intermittent rhythm problem the resting ECG never caught. A murmur heard with the stethoscope needs the echo; a slow pulse needs the ECG; breathlessness with no obvious cause usually needs both. Together they take under an hour and answer a remarkable number of questions.

What they do not answer, alone or together, is the question most readers actually want settled: are my coronary arteries narrowed. Neither test looks at the arteries. An ECG can show the aftermath of an artery that has already blocked, and an echo can show a region of muscle moving poorly because its supply is impaired, but a person with significantly narrowed arteries and no damage yet can have a perfectly normal ECG and a perfectly normal echo on the same afternoon. Answering that question requires a test built for it: exercise or imaging under load in stress testing, calcium in the artery walls in calcium score, a direct non-invasive picture of the arteries in CT coronary angiography, or the catheter study in coronary angiography and stents. Which of those is appropriate depends on your symptoms and your risk profile, and it is a decision to make with a cardiologist rather than by ordering the most impressive-sounding scan available.

Holter monitor and the other ambulatory monitors

A Holter monitor is an ECG that goes home with you. A small recorder, worn on a belt or hung around the neck, is connected to a handful of electrodes on your chest and records every beat continuously while you go about an ordinary day. It exists to solve the central problem described in the ECG section: a resting ECG lasts about ten seconds, and symptoms that come and go rarely have the courtesy to arrive during them.

The whole family of ambulatory monitoring follows one principle — the right monitor is the one likely to be recording when your symptom happens. That makes symptom frequency, not symptom severity, the thing that decides the choice. It is the question you will be asked, and it is worth answering carefully before the appointment: how often, exactly, does this happen. Daily? Twice a week? Once a month? Three times a year?

What a Holter monitor detects

A Holter monitor answers two different questions. The first is correlation: when you feel that thump, that racing, that light-headedness, what is the rhythm doing at that moment? The second is burden, and it has nothing to do with symptoms at all — what your heart does across a whole day and night, including the hours you are asleep.

• Rate across the full day. The slowest and fastest rates reached, and how the rate responds to sleep, waking and effort. A pulse that seems slow in clinic often looks entirely appropriate once the whole day is visible.
• Pauses. Gaps between beats, particularly during sleep, and whether they coincide with anything you felt. This is a common route into the discussion about pacemakers.
• Ectopic burden. How many premature beats there are as a share of the day’s total, whether they are atrial or ventricular, and whether they increase or disappear as the heart rate rises — behaviour that matters more than the raw count, and is discussed in palpitations.
• Runs of abnormal rhythm. Short bursts of a fast rhythm from the upper or lower chambers, and episodes of atrial fibrillation that start and stop on their own — including episodes you never noticed. Where AF is already diagnosed, the question becomes how fast the ventricles run through the day, which no clinic tracing can show.

What it cannot do is look at structure. It records electricity and nothing else, so it says nothing about the valves, the chamber sizes or the strength of the pump — that is the job of the echocardiogram — and it does not image the coronary arteries. Hence a monitor and a scan are often booked together.

How long you wear a Holter monitor

The 24-hour and 48-hour Holter is the standard study. It is the right choice when symptoms occur most days, and equally right when the question is not symptom-driven at all — average heart rate over a full day and night, the total burden of ectopic beats, pauses during sleep, or how well the rate is controlled in known atrial fibrillation. For those questions a single representative day is enough, because you are measuring a pattern rather than hunting a rare event.

Hunting a rare event is a different problem, and it is arithmetic rather than medicine. If something happens once a month, a device recording for one day is unlikely to be present for it, and a normal result then changes almost nothing. So the honest answer to how long you wear a Holter monitor is another question — how often do the symptoms come — and a monitor chosen without asking it is the commonest reason a study has to be repeated. Where symptoms are weeks or months apart, the recording has to be stretched, and the device changes with it.

Patch monitors, event recorders and implantable loop recorders

Beyond the wired Holter there are three further options, each buying more time at some cost in convenience, invasiveness or electrical detail.

Monitor	How long it records	Best for	What it cannot do
Holter monitor	24 hours or 48 hours, continuously.	Symptoms most days, and burden questions: rate day and night, ectopic count, pauses during sleep, rate control in known atrial fibrillation.	Catch anything happening outside those one or two days. The wired recorder cannot get wet.
Patch monitor	Continuously, for up to 7 or 14 days.	Symptoms roughly weekly. One adhesive patch, no box and no wires, waterproof enough to shower in, so it captures considerably more than a 24-hour study by being present for longer.	Swimming and long baths. It also uses fewer ECG leads than a full Holter, so subtler electrical detail can be lost.
Event recorder	Up to about 30 days. It either records only when you activate it, or stores a rolling loop so pressing the button preserves the minutes before as well as after.	Symptoms arriving every few weeks, and symptoms lasting long enough for you to reach the button.	Capture an event that knocks you out before you can press anything, or a silent episode you never feel, unless it loops automatically.
Implantable loop recorder (ILR)	Continuously, for up to around three years, transmitting automatically.	Symptoms weeks or months apart, most often unexplained blackouts, where catching the rhythm during one rare event changes what happens next.	Avoid being a procedure. It is roughly the size of a small paperclip, inserted just under the skin to the left of the breastbone through a tiny incision under local anaesthetic.
Smartwatch or phone single-lead ECG	Brief recordings you start yourself, plus background pulse sampling between them.	A dated trace of something otherwise described from memory. Export it and bring it.	Diagnose. Its own label of “possible AF” or “inconclusive” is not a result until a clinician has looked at the actual trace.

The implantable loop recorder deserves its risks stated plainly, because it is the one option involving an incision. Bruising and discomfort at the site are usual, infection is uncommon but possible and occasionally requires the device to be removed, and the device can sometimes migrate slightly under the skin.

Living with the monitor: showering, sleeping, exercise

Whichever monitor you are given, one instruction matters more than everything else combined. Keep a symptom diary, and write the time. Not “Tuesday afternoon” — the actual clock time, matched to the clock on the recorder if there is one, along with what you were doing and what you felt. The diary, not the tracing, is what converts data into an answer, and a monitor returned with an empty diary reduces a rich recording to a list of unattributable blips.

The practicalities are mostly about keeping the electrodes attached.

• Washing. With a wired Holter the recorder must not get wet, so showering is out for the duration; most people manage with a careful wash. Patch monitors are generally shower-safe but not built for swimming or long baths; follow the instructions supplied with yours.
• Skin. Chest hair is usually clipped where the electrodes go, which improves contact and makes removal less unpleasant. Irritation under the adhesive is common in warm weather — tell the department if you have an adhesive allergy, since alternative electrodes exist. Do not apply creams, oils or talc beforehand, as they stop electrodes sticking.
• Sleeping. Sleep as normal. You can lie on your side, and the recorder can rest beside you.
• Exercise. Exercise as you normally would. The point is to record an ordinary week, not a careful one, and avoiding the activity that provokes your symptoms wastes the study. Heavy sweating can lift an electrode, so check the stickers after exertion; if one comes off, press it back on and note the time.
• Medication. Do not stop any prescribed medication in order to “let the monitor see something” unless the cardiologist who ordered the study has told you to. That applies with particular force to anticoagulation, which is never stopped on your own initiative.

Afterwards the device is returned and the recording processed: software analyses every beat, then a technician and a cardiologist review the flagged sections and the periods matching your diary. This takes days rather than the same afternoon, because a two-week recording contains well over a million beats. Ask when and how you will get the result, and whether it comes with an appointment to discuss it.

Reading the result, and what a normal Holter does not rule out

Three outcomes are worth understanding before the report arrives, and only one is the obvious one.

An abnormal rhythm at a time you felt symptoms is the result everyone imagines. If the recorder captures an abnormality at 14:12 and your diary says your heart was racing at 14:12, the symptom is explained and the treatment discussion can begin.

A normal rhythm at a time you felt dreadful is not a failed test. It is a positive finding of a different kind: it tells your cardiologist that whatever is causing your symptoms is not a rhythm disturbance, which is genuinely reassuring and redirects the search elsewhere.

An abnormal rhythm at a time you felt nothing means something different again. Silent episodes of atrial fibrillation carry implications for stroke prevention whether or not you noticed them, and are treated as a finding rather than an oddity.

Then the limitation to hold on to. A normal Holter monitor does not exclude an arrhythmia. It states one thing only: no significant abnormality occurred during the hours the device was recording. If your symptoms happen once a month and you wore a monitor for one day, a normal result carries almost no information — and if the symptoms continue, the correct response is usually a longer monitor rather than an assumption that nothing is wrong. Nor is it a reason to stop describing what you feel; the description itself, set out in palpitations, still shapes what is looked for next.

Stress testing: exercise ECG, stress echo and nuclear perfusion

A heart at rest can look entirely normal and still be supplied by a narrowed artery. Resting demand is low, and a coronary artery can be substantially narrowed before it fails to keep up with it. A stress test exists to expose that gap. It raises the work the heart is doing, or chemically imitates that demand, and then looks for the part of the muscle that does not get enough blood when it is asked for more.

Every stress test has two halves: how the heart is stressed, and how it is watched while stressed. The two halves are chosen separately, which is why the same patient may be offered a treadmill test in one clinic and a nuclear scan in another. Both are stress tests. They are not equivalent.

How the heart is stressed

Exercise is the first choice whenever you can do it. On a treadmill the speed and gradient step up at fixed intervals; on a stationary bike the resistance rises instead. A bike is often used when balance, weight-bearing or the need for steady images makes walking impractical. Exercise is preferred not only because it is physiological but because it produces information a drug cannot: how long you last, at what workload symptoms appear, how your heart rate and blood pressure respond to effort, how quickly your heart rate settles afterwards, and whether exertion provokes an abnormal rhythm. That information carries weight independently of whether the test shows ischaemia.

Pharmacological stress is used when you cannot exercise adequately — because of arthritis, lung disease, peripheral arterial disease, deconditioning, neurological problems, or simply because you cannot reach a useful workload. Two different drug strategies exist and they are not interchangeable. Dobutamine makes the heart beat faster and harder, genuinely increasing demand, and is paired with echocardiography. Vasodilators — adenosine, regadenoson or dipyridamole — do something less intuitive: they widen healthy arteries far more than diseased ones, so blood is preferentially drawn to well-supplied muscle and the territory beyond a narrowing is left relatively short. That difference is what perfusion imaging photographs.

Stress testing is not appropriate in every situation. Unstable or rest symptoms, a very recent heart attack, severe untreated valve narrowing and uncontrolled arrhythmia are all reasons a team will investigate differently rather than put you on a treadmill. That decision is made before the test is booked, not on the day.

How the stressed heart is watched

Test	What it adds	Honest limitation
Exercise ECG (treadmill test, plain stress ECG)	Symptoms, exercise capacity, rhythm and blood pressure response, ST-segment changes. Quick, no radiation, no contrast.	Judges the heart only through electrical shifts. Misses disease and raises false alarms considerably more often than the imaging tests. Uninterpretable when the resting ECG is already abnormal.
Stress echocardiogram	Watches the heart muscle contract before and at peak stress. A segment that stops thickening normally marks the territory at fault. No radiation.	Depends on image quality and on the operator’s experience. Difficult chest wall anatomy, lung disease or obesity can obscure segments; contrast agents help but do not always solve it.
Nuclear myocardial perfusion imaging (SPECT or PET)	Maps actual blood flow to the muscle using a tracer, at stress and at rest, and shows both reduced flow and scar from previous damage.	Uses a radioactive tracer and takes longer. Artefacts from the diaphragm or breast tissue can mimic disease, and evenly reduced flow in all three arteries can look deceptively normal.

Stress cardiac MRI is a further option in some centres, combining perfusion with detailed muscle and scar imaging and no radiation, though it is less widely available and unsuitable for some implanted devices. Nuclear perfusion studies are performed jointly with nuclear medicine, and PET in particular can quantify flow rather than only compare one region against another.

Why a plain treadmill ECG is often not enough

The exercise ECG reads one thing: the shape of the ST segment as you work. That makes it blind in predictable circumstances. If your resting trace already shows left bundle branch block, a paced rhythm, left ventricular hypertrophy with repolarisation change, pre-excitation, or the effect of digoxin, the ST segments cannot be interpreted and an imaging test should be chosen from the start. If you cannot reach a meaningful workload, the test has not asked the question. And a single narrowed vessel supplying a smaller territory can produce a normal trace.

The accuracy problem is not evenly distributed. In women, the exercise ECG produces false positive results more often, for reasons that include smaller ventricular mass, hormonal effects on the ST segment and a higher rate of disease that is not a discrete blockage at all. That does not make treadmill testing useless in women; it makes an imaging-based stress test the more sensible first choice when the pre-test likelihood of disease is anything other than low. A false positive is not harmless — it leads to further tests, further radiation or contrast, and weeks of avoidable fear.

Preparation, and what it feels like

Written instructions come from the unit performing your test and they differ by test type, so follow the ones you are given rather than a general description. In broad terms you will be asked to come with a light stomach, to wear shoes and clothing you can walk in, and — before vasodilator tests — to avoid caffeine in all its forms for a defined period beforehand, because caffeine blocks the drug and can invalidate the study. Bring a complete list of your medicines. Some drugs are held before certain stress tests; that instruction must come from the doctor who prescribed them, and you should never withhold or alter a cardiac medicine on your own reading of a leaflet.

Electrodes are placed on your chest and you are monitored continuously. Exercise tests feel like brisk uphill walking that becomes hard work; you are meant to reach the point of real effort, and you are asked to say when you have. Dobutamine produces a pounding, anxious, hot sensation. Vasodilators commonly cause flushing, breathlessness and chest heaviness that pass within a minute or two of the infusion ending. Staff stop any test for chest pain, marked ECG change, a fall in blood pressure, a dangerous rhythm or your own request. Tell them what you feel while you feel it — the symptom is part of the result.

What a positive, negative or equivocal result actually leads to

A negative test in someone with a low or intermediate likelihood of disease is genuinely reassuring about flow-limiting narrowing and usually redirects attention to other causes of the symptom. A positive test does not by itself mean a stent. It marks a territory as underperfused and prompts the next decision: optimise medical treatment, image the arteries directly with CT coronary angiography, or proceed to invasive angiography, depending on how severe the finding is, how large the territory is, and how you are symptomatically. An equivocal result — poor exercise capacity, borderline changes, artefact — is common and is not a failure; it usually means repeating the question with a better tool rather than accepting a shrug.

One limitation matters more than all the others, and it is the reason the next test in this pathway exists. A stress test is a search for flow-limiting narrowing. Plaque that lines an artery without yet restricting flow produces a perfectly normal stress test — and that plaque is exactly what ruptures and causes heart attacks. A normal stress test tells you your arteries can meet demand today. It does not tell you your arteries are clean, and it is not a preventive screening tool. That gap is what the coronary calcium score was designed to fill. As with every measurement described here, the result is a signal to be interpreted alongside your symptoms and your risk profile, not a diagnosis on its own.

Nuclear stress test (myocardial perfusion imaging)

A nuclear stress test — formally myocardial perfusion imaging, or MPI — answers a narrower question than its reputation suggests. A small quantity of radioactive tracer is injected into a vein and taken up by heart muscle in proportion to the blood reaching it. A gamma camera or PET scanner then photographs where it went. The image is therefore a map of flow into muscle, not a picture of the arteries themselves: a territory that receives less tracer than its neighbours is a territory whose supply is falling short.

That is why every nuclear stress test acquires two sets of images. One set is acquired with the heart stressed, by exercise or by a vasodilator drug, and one with the heart at rest. Neither is meaningful alone: a single image shows only that one region took up less tracer than another, and cannot say why. The comparison is the result, and the pattern between the two states is what the reporting doctor is reading.

Two patterns matter. A reversible defect is a region that looks short of tracer under stress and normal at rest: living muscle whose supply cannot keep up with demand, which is the signature of a flow-limiting narrowing. A fixed defect looks the same in both states, which usually means scar from previous damage — muscle that will not improve if the artery above it is opened. Mixed patterns are common and are read as both.

The appointment surprises people. Injection, waiting for the tracer to distribute, two separate acquisitions and the gap between them mean a nuclear stress test commonly occupies several hours, most of it spent waiting rather than being scanned. Where a vasodilator is used, avoiding caffeine beforehand is not fussiness — caffeine blocks the drug at the same receptor and can render the whole study uninterpretable. The instructions in preparation apply.

Radiation is genuine and worth stating plainly. A nuclear stress test carries a dose well above a chest X-ray and above a calcium scan; it varies with the tracer and the protocol, and is lower with modern cameras and with PET than with older SPECT technique. Studies are performed with nuclear medicine, and the protocol choice is part of the answer to how much you receive.

A nuclear stress test is chosen over a stress echocardiogram for concrete reasons: poor ultrasound windows, so the muscle simply cannot be seen well; an existing wall-motion abnormality from an old infarct, which makes new abnormality hard to judge; or a need to quantify flow rather than describe it, where PET is the stronger tool.

Coronary calcium score: what the number means and what it does not

The coronary calcium score is the shortest cardiac test most people will ever have. You lie on a CT table with ECG electrodes on, hold your breath once for a few seconds, and it is finished. There is no contrast, no cannula, no needle, no exercise and no drug. The radiation dose is low — in the range of a mammogram rather than a full contrast CT of the chest. Nothing about the experience matches the weight of the number it produces.

The scan looks for calcified plaque in the walls of the coronary arteries. Calcium in a coronary artery is not normal, is not dietary, and is not something you can eat your way into or out of. It is scar-like healing in atherosclerotic plaque, so its presence is direct evidence that the disease process exists in your arteries. Software measures the area and density of every calcified spot and adds them into a single figure, the Agatston score.

The conventional score bands

• 0 — no detectable calcified plaque.
• 1-99 — mild calcified plaque burden.
• 100-399 — moderate calcified plaque burden.
• 400 and above — extensive calcified plaque burden.

These bands are risk-stratification conventions, not verdicts, and they are the same bands used in guidelines worldwide so that clinicians can speak a common language. There is no threshold at which a person becomes a patient. A score is a position on a continuum, and the boundaries are round numbers chosen for convenience.

The absolute figure also means little until it is placed against your age and sex. Calcification accumulates with age, so a modest score in a man of seventy sits in the middle of his peer group, while the same score in a woman of forty-five is markedly unusual and carries a very different implication. This is why reports quote an age- and sex-matched percentile alongside the raw number, and why the percentile often changes the conversation more than the score does. If your report gives only a bare figure, ask for the percentile.

Why a score of zero is reassuring but is not zero risk

A calcium score of 0 is one of the strongest pieces of reassurance available in preventive cardiology. Over the following years, people with no coronary calcium have a low rate of cardiac events, and a zero score frequently justifies a less aggressive preventive strategy in someone whose risk calculation was otherwise borderline.

It is not, however, a clean bill of health, and the reason is mechanical. The scan sees calcium. It cannot see soft, non-calcified plaque — the younger, lipid-rich, inflamed plaque that is disproportionately responsible for sudden rupture and heart attack. Non-calcified plaque is more common in younger adults, in smokers and in people with diabetes, precisely the groups in whom a falsely comforting zero is most costly. A zero score in a 38-year-old smoker with a strong family history does not close the question.

Two consequences follow. First, a zero score never overrides symptoms. If you have chest pain that needs investigating, the calcium score is the wrong test and a normal one must not be used to dismiss you. Second, a zero score does not cancel the risk factors that produced the referral. High blood pressure, abnormal lipids, diabetes and smoking are dangerous whether or not calcium has yet formed.

Why a high score does not mean you need a stent

This is the most common and most damaging misunderstanding of the test. The calcium score measures plaque burden, not narrowing. It says nothing about whether any artery is obstructed, and heavily calcified arteries can have entirely adequate flow while a modestly calcified artery can harbour a critical narrowing. There is no calcium score that indicates a stent, and a high score in someone with no symptoms is not a reason to go to the catheter lab.

What a high score does mean is that your future risk is higher than your risk calculator estimated, sometimes considerably higher, and that the case for intensive prevention is correspondingly stronger — blood pressure control, lipid-lowering treatment, diabetes management, smoking cessation and physical activity, discussed in prevention and screening. Which of those apply to you, at what intensity, and with which medicines is a decision for the doctor who knows your full history and monitors you over time. Do not start, stop or change any cardiac medicine because of a number on a scan report.

A high score in someone who also has symptoms is a different situation entirely, and moves the question to the tests described in CT coronary angiography and stress testing.

Who benefits from the test, and who should not have it

The calcium score earns its place in one specific situation: an adult without symptoms whose estimated risk sits in the intermediate range, where the decision about preventive drug treatment is finely balanced and could reasonably go either way. Here the scan genuinely changes management in both directions — upgrading treatment in some, safely withholding it in others. It is also useful when a family history of early coronary disease sits uncomfortably against otherwise unremarkable risk factors, or when someone is reluctant to start long-term treatment and wants evidence from their own arteries.

It is the wrong test for several groups. If you already have known coronary disease, a previous heart attack, a stent or bypass grafts, the answer the scan gives is already known and treatment is already indicated. If you have symptoms that need investigating now, the calcium score does not answer that question and delays the tests that would. If your risk is already clearly high — established diabetes with other risk factors, familial hypercholesterolaemia, severe hypertension — treatment is indicated regardless of the score, and a low score should not be used to argue against it. Very young adults will usually score zero simply because calcification takes time.

Two practical honesties. The scan images part of the chest, so incidental findings — lung nodules, pleural changes, thyroid abnormalities — occur and may generate follow-up you did not anticipate; ask beforehand how the unit handles them. And repeat scanning is rarely as informative as people expect. Scores tend to rise over time even with excellent treatment, partly because stabilising plaque calcifies it, so a rising score is not proof that treatment has failed. Routine repeat scanning at short intervals is not standard practice, and the interval, if any, is a discussion with your doctor rather than a default.

CT coronary angiography: seeing inside the artery without a catheter

CT coronary angiography — CTCA, sometimes written coronary CT angiography or CCTA — is a different test from the calcium score despite using the same scanner, and confusing the two leads to real misunderstanding. The calcium score is a quick, contrast-free look for calcification in the artery wall. CTCA involves an intravenous cannula, an iodinated contrast injection, a higher radiation dose and a longer, more demanding acquisition, and in return it shows the inside of the artery: the channel blood actually travels through, the plaque narrowing it, and the character of that plaque — calcified, non-calcified or mixed. Where the calcium score answers “is there disease and how much”, CTCA answers “where is it and how tight is it”.

What CTCA is best at

Its greatest strength is negative. In a patient with chest pain and a low-to-intermediate likelihood of coronary disease, a good-quality CTCA showing clean arteries is powerfully effective at ruling out obstructive coronary disease, and it does this better than any functional test. That is why it has become the first-line investigation for stable chest pain in many guidelines. A normal scan allows the search to move on to the oesophagus, the chest wall, the lungs or anxiety with genuine confidence rather than lingering doubt, and it spares a great many people an invasive procedure.

It is also informative when it is not normal. CTCA characterises plaque as well as measuring stenosis, and features such as low-attenuation plaque, positive remodelling and spotty calcification carry prognostic weight beyond the degree of narrowing. A scan showing extensive non-obstructive plaque changes the prevention conversation even though no artery needs opening. Reports frequently use a structured scale, CAD-RADS, to summarise severity in a way other clinicians can act on consistently; ask the reporting doctor what your category implies rather than searching for it.

Where CTCA struggles

The scan freezes a moving object, so the heart’s behaviour during the acquisition determines image quality. A slow, steady rate — commonly around 60 beats per minute or below — is needed, and the unit will often give a rate-slowing medicine before the scan and a nitrate spray to widen the arteries. Both are given and supervised by the imaging team; neither is anything you arrange yourself. An irregular rhythm such as atrial fibrillation, frequent ectopic beats, or an inability to hold your breath for the required seconds all degrade the study, though newer scanners tolerate irregularity far better than earlier generations did.

Heavy calcification is the second limitation and the one that most often defeats the test. Dense calcium blooms on CT, spreading beyond its true borders and obscuring the channel underneath, so a severely calcified artery may be reported as non-diagnostic or as an overestimate of narrowing. The same blooming affects metal, which is why CTCA is unreliable for assessing the inside of most coronary stents and of limited use after bypass grafting for the native vessels. In these situations a functional test or an invasive study is the more sensible route.

Contrast and kidneys must be considered before booking. Iodinated contrast can affect kidney function in people with pre-existing impairment, dehydration or diabetes, and previous contrast reactions must be declared. The team will ask about kidney function, allergies, asthma, thyroid disease, pregnancy and the possibility of pregnancy, and about metformin. Radiation is real, though doses have fallen substantially with modern scanners and prospective gating; it is still a reason not to order the scan casually or repeat it without cause. Imaging is performed with radiology, and the quality of the study depends as much on protocol and reporting experience as on the machine.

Anatomy is not the same as function

CTCA shows what an artery looks like. It does not show whether a narrowing is actually starving the muscle downstream, and the relationship between the two is looser than intuition suggests. A narrowing that appears alarming on the images may be perfectly well tolerated; a modest-looking one in a long vessel supplying a large territory may not be. Treating pictures rather than physiology leads to stents that do not help.

Two routes bridge that gap. Fractional flow reserve derived from the CT dataset — FFR-CT — uses computational modelling of the scan to estimate the pressure drop across a narrowing, so the anatomical study can be given a functional answer without a second appointment. Alternatively, a functional test such as those described in stress testing can be added. Either way the question being asked is the same one the pressure wire answers in the catheter lab, described in coronary angiography and stents, and the same threshold governs the interpretation.

What follows the scan is therefore a range rather than a binary. Clean arteries redirect the diagnosis. Non-obstructive plaque triggers prevention rather than intervention. An intermediate narrowing triggers a functional assessment. Severe disease, particularly involving the left main artery or the proximal vessels, or a scan that cannot be interpreted in someone with convincing symptoms, leads to invasive angiography. The scan is a step in a decision, not the decision.

Coronary angiography, angioplasty and stents

Coronary angiography is the reference standard for looking at the coronary arteries. A fine catheter is passed through an artery in your wrist or groin, guided to the origin of the coronary arteries, and contrast is injected while X-ray images run, so the arteries appear as moving black channels. It is invasive, but it is also the only test that can become treatment in the same sitting — which is why consent is normally taken for both the diagnostic study and, if appropriate, the intervention that may follow immediately.

Radial or femoral, and what it feels like awake

Most planned angiograms today use radial access at the wrist. Radial access causes fewer serious bleeding complications than the groin and lets you sit up and walk soon afterwards, which is why it has become the default. Femoral access at the groin is still used when the wrist arteries are too small or spastic, when previous grafts or larger devices need a bigger sheath, or when the radial route fails.

You are awake. Light sedation may be offered but you are not anaesthetised, because your cooperation with breath-holds and your description of symptoms are useful. Local anaesthetic stings for a moment at the puncture site; after that the catheters themselves are not felt, as arteries have no sensation along their length. Contrast injections into the coronary arteries can produce a brief warm or heavy feeling. The table moves, the camera swings close to your face, and staff will ask you to hold your breath repeatedly. Most people find the anticipation harder than the procedure.

Angioplasty, drug-eluting stents and the pressure wire

If a narrowing needs treating, a fine wire is passed across it, a balloon is inflated to compress and crack the plaque outward — angioplasty — and in almost all cases a stent is deployed to hold the vessel open. A stent is a small metal scaffold; once expanded it is permanent, and the artery lining grows over it in the following weeks.

Nearly all stents used now are drug-eluting stents. The metal is coated with a polymer carrying an antiproliferative drug — the sirolimus and paclitaxel families — released over weeks to suppress the exuberant scar-tissue overgrowth that used to renarrow bare metal stents from within. That overgrowth, restenosis, is the problem the coating exists to solve, and modern drug-eluting stents with thinner struts have made it much less common. They have not abolished it, and renarrowing remains a reason for recurring symptoms months or years later.

Not every narrowing that looks significant is significant, and this is where the pressure wire matters. A wire with a pressure sensor is passed beyond the narrowing and the pressure drop across it measured, giving the fractional flow reserve — a value at or below roughly 0.80 indicates that the narrowing genuinely limits flow, while a higher value indicates it does not. Resting indices such as iFR give equivalent information without a drug infusion. The point is not the arithmetic: it is that stenting an angiographically impressive lesion that is not flow-limiting exposes you to the risks of a stent and lifelong implications with no symptomatic gain. Intravascular imaging with IVUS or OCT is used similarly, to size vessels properly and confirm the stent is fully expanded.

The risks of angiography and stenting

Coronary angiography is performed constantly and is usually uneventful, but it is an invasive arterial procedure and it carries real complications that must be part of your consent conversation:

• Access site problems — bruising is very common; a painful haematoma, a pseudoaneurysm, or an arteriovenous fistula are less common, and are more frequent with femoral than radial access. Radial arteries can occlude after the procedure, usually without consequence.
• Contrast effects on the kidney, particularly with pre-existing impairment, dehydration or diabetes, and allergic reactions to contrast.
• Radiation exposure, higher for a long intervention than a short diagnostic study.
• Stroke, caused by dislodged material or clot travelling from the catheter — uncommon, but among the most serious risks.
• Arrhythmia during the procedure, including rhythms requiring immediate treatment.
• Damage to a coronary artery — dissection or perforation — which can require emergency treatment, and rarely urgent cardiac surgery, which is why interventional programmes maintain surgical arrangements.
• Heart attack, and rarely death. These are unusual outcomes of a planned procedure but they are not zero, and a page that omitted them would be dishonest.

Risk is not the same for everyone. It rises with age, kidney impairment, poor ventricular function, complex disease and emergency rather than planned circumstances. Ask for the assessment that applies to you, in your own consultation, rather than working from a general description.

Stent versus bypass: a heart team decision

For single narrowings and much multivessel disease, stenting and surgery both remain reasonable, and the choice is made by a heart team — an interventional cardiologist, a cardiac surgeon and your own cardiologist reviewing your images and your history together — rather than by whichever specialist you happened to see first. The factors that move the decision are the number and pattern of diseased vessels, involvement of the left main artery, the complexity and calcification of the lesions, whether you have diabetes, your ventricular function, kidney disease, frailty and age, whether complete revascularisation is achievable by catheter, and your own priorities regarding recovery time and durability.

Coronary artery bypass grafting takes a different approach: rather than opening the narrowing, new conduits are attached beyond it to restore supply, which tends to favour surgery in diabetic patients and in extensive multivessel or left main disease. How that operation is performed, what recovery involves and how grafts behave over time belongs with cardiovascular surgery.

After a stent: the instruction that matters most

After a stent you will be prescribed dual antiplatelet therapy — aspirin together with a second antiplatelet drug such as clopidogrel, ticagrelor or prasugrel — for a period that is individualised, commonly somewhere between six and twelve months, and sometimes shorter or longer depending on bleeding risk, the complexity of the stenting and whether you also need an anticoagulant. Aspirin usually continues indefinitely afterwards. All of this is prescribed and monitored by your own cardiologist.

Never stop these medicines on your own initiative. Stopping antiplatelet treatment early, or interrupting it without cardiological advice, can allow a clot to form inside the stent. Stent thrombosis is abrupt, presents as a major heart attack, and is catastrophic. If any other doctor or dentist proposes stopping your antiplatelet drugs before a procedure — dental extraction, endoscopy, cataract surgery, any operation — the decision belongs to the cardiologist who placed your stent, and many procedures can proceed without stopping anything at all. Carry your stent card, and tell every clinician you have a stent and when it was placed. Bleeding that you cannot stop — blood in vomit or stool, black tarry stool, a nosebleed that will not settle, or bleeding with faintness — is an emergency on these medicines.

Chest pain and angina: reading the pattern

Most chest pain is not the heart. That statement is true and it is also the reason chest pain is taken seriously every time: the minority that is cardiac is time-critical, and no pattern is reliable enough to be dismissed over the phone. What clinicians do is read the pattern, and understanding how they read it will tell you a great deal about your own symptom.

Angina is the specific symptom produced when heart muscle receives less blood than it is asking for. Classically it is not a sharp pain at all. People describe pressure, tightness, heaviness, squeezing, a band, a weight, sometimes only breathlessness or an odd discomfort in the jaw, throat, shoulder or arm. It appears with effort or emotion, is fairly reproducible at a similar level of exertion, and eases within minutes of stopping. Cold weather, a heavy meal and walking uphill all make it appear sooner.

More suggestive of a cardiac cause	More suggestive of another cause
Pressure, tightness or heaviness rather than sharpness	Sharp, stabbing or knife-like
Brought on predictably by exertion or emotion	Present at rest and unchanged by activity
Relieved within minutes by rest	Lasting a few seconds only, or continuous for days
Central, spreading to arm, jaw, throat, shoulder or back	Reproduced exactly by pressing on the chest wall
Accompanied by breathlessness, sweating or nausea	Clearly worse on twisting, bending or deep breathing
Occurring in someone with several vascular risk factors	Burning, related to meals or lying flat, with an acid taste

No single feature settles it. A cardiac pain can be atypical and a musculoskeletal pain can be frightening. The table describes probabilities, not rules, and it is used alongside your age, sex, risk factors, ECG and — where indicated — the tests described in stress testing and CT coronary angiography.

Stable angina, and the change that is not a clinic problem

Stable angina means the symptom is predictable: the same trigger, the same intensity, the same relief, over weeks or months. It is a chronic condition, treated with medicines that reduce the heart’s demand and with aggressive risk-factor control, and revascularisation is considered when symptoms persist despite treatment or when the anatomy carries prognostic weight.

What changes everything is a change in the pattern. Angina that appears at rest, angina that comes on at a much lower workload than last month, angina that lasts longer or is no longer relieved by rest, or angina appearing for the first time — these describe an unstable situation, not a stable one.

The causes that are not the heart

When cardiac causes are excluded, the remaining explanations are real conditions that deserve treatment rather than a shrug. Musculoskeletal pain — costochondritis, intercostal muscle strain, cervical or thoracic spine referral — is the largest group; it is typically reproduced by pressing on the chest wall or by particular movements, and it can last weeks. Gastro-oesophageal reflux and oesophageal spasm produce burning or gripping central chest pain that is genuinely difficult to distinguish from angina, sometimes even responding to the same nitrate medicines. Anxiety and panic cause chest tightness, breathlessness, tingling and a pounding heart, and the symptom is physical, not imagined; being told “it is only anxiety” without an explanation helps nobody. Pleuritic pain, sharp and worse on breathing in, points to the lung or its lining. Some of those lung causes are themselves emergencies.

When there is no chest pain at all

A significant proportion of coronary disease presents without the textbook symptom, and three groups are consistently under-recognised. Women more often report breathlessness, unusual fatigue, nausea, or discomfort in the back, jaw or upper abdomen rather than central chest pressure, and are more likely to have their symptoms attributed to anxiety or reflux before a cardiac cause is considered. People with diabetes may have blunted pain perception from autonomic neuropathy and can have substantial ischaemia with little discomfort. Older adults frequently present with breathlessness, confusion, falls or simply not being themselves. If you belong to one of these groups and something has changed in your exercise tolerance, that change deserves assessment even without pain.

Angina with normal arteries

Some people have convincing, disabling angina and a normal angiogram. That combination is not a mistake and it is not psychological. Microvascular angina arises in the smallest coronary vessels, which are far below the resolution of any angiogram: the large arteries look clean while flow reserve in the microcirculation is impaired. Vasospastic angina is caused by transient spasm of an epicardial artery, characteristically at rest and often at night or in the early morning, and can be severe enough to cause ECG changes and, uncommonly, infarction.

Both are diagnosable. Coronary flow reserve measurement, microvascular resistance indices and provocation testing during angiography can establish which mechanism is at work, and both have specific medical treatments prescribed and monitored by a cardiologist. The practical message is simple: a normal angiogram does not always mean a normal heart, and if you have been discharged with unexplained exertional chest pain and no diagnosis, that is a reason to ask the question again rather than to accept it.

Heart attack: symptoms, troponin and what happens next

A heart attack — myocardial infarction — happens when blood flow to part of the heart muscle stops or falls catastrophically and that muscle begins to die. In the commonest form, a plaque in a coronary artery wall ruptures or erodes, the body treats the break as an injury and forms a clot on it, and the clot occludes the vessel within minutes. The plaque involved is often not the tightest one; a modest, inflamed, lipid-rich plaque that never limited flow and never caused angina is a frequent culprit, which is why heart attacks strike people who passed a stress test.

Muscle deprived of blood does not die instantly but it dies progressively, and once dead it is replaced by scar that never contracts again. Everything about emergency treatment is organised around that single fact: the interval between occlusion and reopening determines how much muscle survives.

Heart attack symptoms

The recognisable presentation is chest pain or pressure lasting more than a few minutes. It may begin at rest, and unlike angina it does not settle within minutes when you stop. The classic features are:

• Chest pain or pressure — heaviness, tightness, crushing, or a band across the chest, lasting more than a few minutes.
• Pain spreading to one or both arms, the jaw, the throat, the neck, the shoulders or the back.
• Sweating, often cold and profuse.
• Nausea or vomiting.
• Breathlessness, with or without the chest pain.
• Light-headedness, or an overwhelming sense that something is badly wrong.

The presentations that get missed are the ones without that pain, and they are not rare:

• Sudden unexplained breathlessness alone.
• Profound fatigue or weakness.
• Nausea and vomiting mistaken for a stomach upset.
• Upper abdominal discomfort mistaken for indigestion.
• Sudden confusion or collapse in an older person.
• A cold sweat with no pain at all.

These atypical presentations are more common in women, in people with diabetes, in older adults, and after cardiac surgery or transplantation.

A heart attack and a cardiac arrest are not the same event. In a heart attack the person is conscious and the artery is blocked; in a cardiac arrest the heart stops pumping and the person is unresponsive and not breathing normally. A heart attack can cause a cardiac arrest. If someone collapses and is unresponsive and not breathing normally, call your local emergency number, start chest compressions and send for the nearest defibrillator.

Troponin: why one number is not the answer

Troponin is a protein inside heart muscle cells. When those cells are damaged, troponin leaks into the blood, and modern high-sensitivity assays detect very small quantities, which is why troponin has become the central blood test in the assessment of chest pain.

Its sensitivity is also its complication. A raised troponin means heart muscle injury; it does not by itself mean a heart attack. Troponin rises in myocarditis, in pulmonary embolism, in sepsis, in kidney impairment, in severe heart failure, in fast arrhythmias, after prolonged strenuous exercise, and in a great many acutely unwell patients whose coronary arteries are entirely normal. Distinguishing injury from infarction requires the clinical picture, the ECG and often imaging — which is why nobody should be given a diagnosis over the telephone on the strength of one figure.

Equally important, a single value taken early can be normal while an infarct is in progress, because the protein takes time to appear in the blood. This is why emergency departments take troponin more than once. The change between two samples — the rise or fall over a defined interval — carries more diagnostic weight than either individual number, and a flat, unchanged low value over an appropriate interval is what allows safe discharge. If you have been told your troponin was “slightly raised”, ask what the second value did and what the team concluded from the pair. A test result is a signal to be interpreted, not a diagnosis on its own.

STEMI and NSTEMI, and what “opening the artery” means

The ECG divides heart attacks into two management pathways within minutes of arrival. A STEMI — ST-elevation myocardial infarction — shows a characteristic pattern indicating that a major coronary artery is completely occluded right now, and the entire system is built to reopen it as fast as possible. The preferred treatment is primary PCI: emergency coronary angiography with the clot removed or crossed, the artery reopened with a balloon and almost always held open with a stent, using the techniques described in coronary angiography and stents. Where a catheter laboratory cannot be reached quickly enough, a clot-dissolving drug is given first and angiography follows.

The concept clinicians use is door-to-balloon time: the interval from arriving at a capable hospital to the moment flow is restored. Systems measure it, publish it and reorganise around shortening it. The delay between symptom onset and calling for help is typically far longer than anything that happens inside the hospital.

An NSTEMI — non-ST-elevation myocardial infarction — means muscle damage has occurred, confirmed by troponin, without that complete-occlusion pattern on the ECG. The artery is usually severely narrowed or intermittently blocked rather than permanently occluded. Treatment begins with medicines that suppress clotting and reduce cardiac work, followed by angiography on a planned urgent basis, with the timing decided by risk assessment rather than by the clock in the same way as a STEMI. It is not a “small” heart attack, and it is not a lesser diagnosis.

Life after a heart attack

Once the artery is treated, the work shifts to protecting the rest of the heart. An echocardiogram assesses how much muscle was affected and what the pumping function now is, discussed in ejection fraction. You will be discharged on several medicines, typically including antiplatelet therapy, a lipid-lowering drug, and agents that reduce the heart’s workload and protect against remodelling. Each is prescribed and monitored by your own doctor, and the antiplatelet rules after a stent — above all, not stopping them on your own — apply in full.

Cardiac rehabilitation is the part most often skipped and least often regretted: a supervised programme of graded exercise, education, risk-factor management and psychological support, described further in prevention and screening. Structured rehabilitation improves symptoms, confidence and long-term risk-factor control in a way that no tablet replaces. Low mood and anxiety after a heart attack are common, normal and treatable, and they affect recovery; say so rather than absorbing it. Questions about returning to work, driving, flying and sexual activity have real answers that depend on what happened to you and how your heart is functioning — ask your own team rather than guessing.

One honest thing to hold on to. A heart attack is a permanent change in your risk status, not an episode you recover from and leave behind. The plaque that ruptured was one of many, the process that produced it is still active, and secondary prevention is lifelong. That is not a counsel of despair — it is the reason consistent treatment and follow-up matter so much, and the reason a repeat event is far less likely in someone who stays engaged with their care than in someone who feels better and stops.

Palpitations, skipped beats and ectopic heartbeats

A heart palpitation is not a diagnosis. It is a symptom, and the symptom is simply this: you have become aware of your own heartbeat when normally you would not notice it at all. The heart may be beating perfectly normally and you have become conscious of it. It may be beating harder, or faster, or with an interruption that lands in your chest like a dropped step on a staircase. All three feel frightening. Most of them are harmless.

In no other area of cardiology does the fear run so far ahead of the findings. The majority of people investigated for palpitations have a structurally normal heart and a rhythm disturbance that carries no threat to life. But “most” is not “all”, and a small number of them are the first outward sign of something that genuinely needs treating. The job of the assessment is to separate the two, not to reassure you before anyone has looked.

What your description tells a cardiologist before any test

How you describe the sensation narrows the field more than patients expect, often more than the first ECG does — because the ECG only captures the rhythm that is happening while the electrodes are attached, and palpitations rarely oblige. Different descriptions point in different directions.

• A single thud, flip or lurch, often described as a missed beat followed by an unusually strong one. This is the signature of an ectopic beat. The beat you feel as “missing” is in fact the extra beat: it arrives too early to have filled the ventricle, so it produces little pulse. The thump afterwards is the next normal beat, ejecting a fuller chamber after a pause.
• A sustained regular fast rhythm that begins and ends abruptly, like a switch being thrown, often with a pounding sensation in the neck. That pattern suggests a re-entrant tachycardia, described in the section on supraventricular tachycardia.
• A fast rhythm with no pattern whatsoever — patients often tap it out on the desk and cannot find a beat to tap to. Irregular and disorganised points towards atrial fibrillation.
• A gradual pounding that builds and then fades, usually with a reason attached: exertion, fright, fever, pain. This is ordinary sinus tachycardia, the heart doing what it is designed to do in response to a demand.

None of these is diagnostic on its own; they shape which test comes next, and how urgently. The choice of monitor — and how long you wear it — belongs to the section on Holter monitoring and event recorders, because that depends entirely on how often your symptoms happen.

Ectopic beats: PACs, PVCs and why they are usually left alone

An ectopic beat is an electrical impulse that fires early, from somewhere other than the heart’s normal pacemaker. If it starts in the upper chambers it is a premature atrial contraction (PAC). If it starts in the lower chambers it is a premature ventricular contraction — a PVC, the term most people arrive with after searching a monitor report.

Almost every adult heart produces ectopic beats. Wear a monitor for a day and they will be found. Whether you feel them has very little to do with how many there are: people with a handful notice every one, people with thousands discover them incidentally. They are most noticeable at rest, in the evening, lying on the left side — precisely when nothing else is distracting you from your own chest. In a structurally normal heart they generally require no treatment at all. That is not dismissal; it is the honest answer, and hearing it clearly after a proper look is usually what settles the symptom.

Ectopy is investigated more thoroughly in specific situations: when the beats are very frequent, making up a large share of the day’s total beats; when they increase with exertion instead of disappearing as the rate rises, which is the concerning direction; when they come with faintness or genuine breathlessness; when they arrive in runs rather than singly; when the heart is already abnormal after a previous heart attack or with reduced pump function; or when there is a family history of unexplained sudden death. A very high PVC burden sustained over months can itself weaken the pumping muscle — a recognised and largely reversible form of cardiomyopathy, which is why frequent ectopy is paired with an echocardiogram rather than judged on a rhythm strip alone.

Triggers, described proportionately

Caffeine, alcohol, nicotine, dehydration, a short night’s sleep, stress, fever, an over-the-counter decongestant, an overactive thyroid, anaemia, pregnancy and the perimenopause all make palpitations more likely or more noticeable. Some stimulant medicines and some inhalers do the same, as does a heavy meal, and so does simply paying attention.

Two honest qualifications. Caffeine is blamed far more often than the evidence supports, and cutting it out entirely is worth trying for a fortnight rather than assuming. Alcohol is under-blamed — it is the most reliably reproducible trigger people find when they keep an accurate diary. And anxiety sits on both sides of the relationship: it provokes palpitations, and palpitations provoke it. Naming that loop is not the same as calling the symptom imaginary. It is physiological, and it is easier to break once the heart itself has been checked.

The features that change the picture entirely

Some combinations move palpitations out of the reassurance category before any monitor is ordered: with chest pain or pressure; with breathlessness out of proportion to what you are doing; with fainting or near-fainting, particularly during exertion rather than after it; in someone with a previous heart attack, reduced pump function or a known cardiomyopathy; and in anyone whose close family includes a sudden unexplained death at a young age. Any of these is assessed properly and promptly, not watched.

Atrial fibrillation

Atrial fibrillation — AF, or afib — is the most common sustained heart rhythm disorder in adults. Normally one impulse starts in the sinus node and sweeps down in an orderly wave. In AF the atria are overwhelmed by rapid chaotic activity firing from many points at once, much of it around the openings of the pulmonary veins. The atria quiver instead of contracting, and the AV node lets through an unpredictable selection of those impulses — which is why the pulse in AF is irregular in a way no other common rhythm matches: irregularly irregular, with no repeating pattern to find.

Two consequences follow, and they are entirely separate. Blood moves sluggishly in an atrium that is not contracting, so clot can form — the basis of the stroke risk covered in stroke prevention in atrial fibrillation. And the loss of atrial filling, with a fast irregular ventricular rate, makes many people feel unwell: breathless, tired, light-headed, unable to manage exercise they managed last month. Keeping those apart is the most important idea in this section.

Paroxysmal, persistent and permanent

AF is classified by how it behaves over time, and the label shapes what is worth attempting.

• Paroxysmal AF comes and goes, stopping by itself, usually within a day and by definition within seven days. Between episodes the rhythm is entirely normal, which is why a resting ECG in clinic so often looks perfect.
• Persistent AF continues beyond seven days, or requires cardioversion or drugs to stop it. When it has been continuous for more than a year and a rhythm-control strategy is still being pursued, it is often called long-standing persistent.
• Permanent AF is not a different disease. It is a decision: you and your cardiologist have agreed to stop trying to restore normal rhythm and to manage the rate instead. The word describes a plan, not a prognosis, and the plan can be revisited.

AF tends to progress along that sequence, because fibrillation remodels the atrial tissue and makes further fibrillation easier. That is the argument for treating it seriously early.

How AF is diagnosed, and why it is so often silent

Diagnosis requires the rhythm to be recorded electrically. A standard ECG confirms it instantly when AF is present at that moment — the absent P waves and irregular ventricular response are unmistakable, and the section on reading an ECG report explains the terms. When AF comes and goes, the recording has to be stretched over time, which is the purpose of the devices described in the monitoring section.

A large proportion of AF produces no symptoms at all, and is found on a routine ECG, by a blood pressure machine flagging an irregular pulse, or increasingly by a smartwatch. Consumer devices genuinely prompt diagnoses and they also produce false alarms: a notification from a watch is a reason to obtain a medical-grade recording, not a diagnosis and not a reason to start treatment. Silent AF carries the same stroke risk as noisy AF, which is why a symptomless finding is still treated as a finding.

The two jobs of afib treatment, which are constantly conflated

Almost every confusion about afib treatment comes from collapsing two independent decisions into one. They are decided separately, by different criteria, and the answer to one tells you nothing about the other.

Job one is preventing stroke, driven by your individual risk profile — not by how you feel, and not by whether your rhythm has been restored. Someone whose AF is now controlled and symptom-free may still need lifelong anticoagulation. This is covered in stroke prevention in atrial fibrillation.

Job two is controlling symptoms, driven by how much the arrhythmia is affecting your life. Rate control accepts the AF and slows the ventricular response so the heart fills better. Beta blockers, certain calcium channel blockers and occasionally digoxin are the classes used, and this is often the sensible first approach in older people with few symptoms and long-standing AF.

Rhythm control aims to restore and maintain sinus rhythm, using antiarrhythmic medication, cardioversion or catheter ablation. It is favoured in younger people, where symptoms persist despite adequate rate control, in AF of recent onset, and in AF alongside heart failure, where restoring rhythm can improve pump function.

Which strategy suits you depends on your age, symptom burden, how long the AF has been present, atrial size, other heart disease and your own preference, and it is reasonable to change course later. What is not negotiable is that neither strategy replaces job one. Every drug named here is prescribed and monitored by your own doctor; none is started, stopped or adjusted on the basis of anything read here.

Cardioversion, and why it usually cannot be done today

Cardioversion resets the heart to sinus rhythm. Electrical cardioversion delivers a brief synchronised shock through pads on the chest while you are under short sedation or a light general anaesthetic, so you are asleep for it. Pharmacological cardioversion uses an intravenous or oral antiarrhythmic drug given under monitoring. Electrical cardioversion works more reliably and more quickly; the drug route avoids an anaesthetic.

The frustrating part, for patients expecting it to be sorted the same afternoon, is the clot precaution. Restoring coordinated atrial contraction can dislodge a clot that formed while the atrium was quivering, causing a stroke at the moment of the reset. So if AF has been present for more than 48 hours, or the duration is unknown, one of two things must happen first: either at least three weeks of properly maintained anticoagulation beforehand, or a transoesophageal echocardiogram — a probe passed into the oesophagus, which lies directly behind the left atrium — to confirm there is no clot in the appendage. Anticoagulation continues for at least four weeks afterwards regardless, because the atrium takes time to recover mechanical function even once the rhythm looks normal, and often continues indefinitely depending on your stroke risk.

Cardioversion restores rhythm; it does not cure AF. Recurrence is common and is not a failure of the procedure — it is information about how established the AF has become, and it feeds into whether ablation is worth considering.

Atrial flutter, and how it differs from AF

Patients told they have “flutter, not fibrillation” are left wondering whether that is better or worse. It is neither; it is different in mechanism. In atrial flutter the atrial activity is not chaotic at all — it is a single organised wavefront circling a fixed anatomical loop, most commonly around the tricuspid valve in the right atrium. Because the circuit is regular, the pulse in flutter is typically regular and fast rather than irregular, and the ECG shows a sawtooth baseline instead of absent P waves. Symptoms are often more pronounced, because the rate tends to be high and steady, and flutter can be more stubborn to rate-control with medication.

The critical similarity: flutter carries a stroke risk managed exactly as in AF, with the same assessment and the same anticoagulation logic. Nobody is spared anticoagulation because their arrhythmia is flutter. The critical difference: because the circuit is anatomically predictable, ablation of typical flutter is a far more straightforward proposition than AF ablation and is often offered earlier. The two also travel together — many people with flutter develop AF later, and monitoring after flutter ablation looks for exactly that.

The drivers worth treating, which are not lifestyle garnish

AF is often described as if it appears from nowhere. Frequently it does not, and several of its drivers respond to treatment well enough that addressing them is part of the therapy rather than an afterthought. Rhythm control works better when they are dealt with, and ablation results are worse when they are ignored.

• Weight. Sustained weight reduction in people carrying significant excess weight reduces AF burden and symptoms, and the effect is dose-dependent. It is one of the better-evidenced interventions in rhythm management and deserves structured support rather than a leaflet — that work sits with nutrition and dietetics.
• Alcohol. The relationship is direct and dose-related, and reducing intake reduces recurrence. For some people alcohol is the single identifiable trigger of every episode they have had.
• Obstructive sleep apnoea. Under-diagnosed in AF and strongly associated with it; untreated, it makes both drug therapy and ablation less durable. If you snore heavily, wake unrefreshed or have been told you stop breathing at night, say so — a sleep study changes management.
• Blood pressure. Long-standing hypertension stretches and stiffens the left atrium, which is the substrate AF grows in. Control is addressed in the blood pressure section.
• Thyroid function. An overactive thyroid can precipitate AF outright, and it is checked in essentially everyone presenting with new AF, because treating it can resolve the arrhythmia.
• Diabetes and glucose control — and, at the other extreme, very high-volume endurance exercise sustained over many years, independently associated with AF in a way that surprises the athletes it affects.

Catheter ablation

Cardiac ablation treats an arrhythmia by deliberately destroying or electrically isolating the small area of heart muscle responsible for it. No incision is made in the chest. Thin steerable catheters are passed into a vein at the top of the leg and advanced into the heart under X-ray guidance. Once inside, they record the heart’s own electrical signals, and a three-dimensional map of the chamber is built on screen, colour-coded by timing and voltage. That map turns the procedure from guesswork into targeting. It is done under sedation or general anaesthesia; AF ablation in particular is long, and lying completely still for it is the harder part.

Pulmonary vein isolation for atrial fibrillation

In most people with paroxysmal AF, the impulses that start an episode arise from sleeves of atrial muscle extending into the pulmonary veins. Pulmonary vein isolation is the cornerstone of AF ablation: a continuous ring of ablated tissue is created around the veins so that whatever fires inside them can no longer escape into the atrium. Reaching the left atrium requires a transseptal puncture — a controlled crossing through the thin wall between the upper chambers, which heals on its own. In persistent AF, where the atrial tissue has been remodelled, additional lines may be added, and results are less predictable.

Radiofrequency, cryoballoon and pulsed field

Several energy sources are in routine use, usually presented as a specification sheet. What matters is what each changes for you.

Radiofrequency heats tissue at the catheter tip, burning point by point to draw a line. It is the most versatile approach — a lesion can be placed anywhere and the line shaped to your anatomy — which is why it remains the default for complex or repeat cases. Drawing a continuous, durable ring that way takes skill and time.

Cryoballoon ablation inflates a balloon in the opening of each pulmonary vein and freezes a circle of tissue in one application. It is faster and highly reproducible for straightforward isolation, less adaptable when the anatomy is unusual, and freezing near the right-sided veins carries a specific risk to the phrenic nerve, which runs close by and supplies the diaphragm.

Pulsed field ablation uses short high-voltage pulses rather than heat or cold. Heart muscle is markedly more susceptible to them than the surrounding oesophagus, phrenic nerve and blood vessels, so the expected risk of the collateral injuries that make thermal ablation dangerous in rare cases is lower, and procedures are shorter. It carries its own risks and it is not a different operation — the access, the transseptal puncture and the vascular risks are unchanged.

Ablation for SVT, flutter and ventricular ectopy

Grouping all ablation under one heading misleads people, because the range in complexity is enormous. Ablation for a common re-entrant supraventricular tachycardia is a short, right-sided procedure that usually does not require crossing into the left atrium at all, targets a circuit a few millimetres across, and is frequently curative — many people never have another episode. Ablation of typical atrial flutter targets a single well-defined isthmus and is similarly contained. AF ablation is longer, left-sided, with a meaningful recurrence rate and a genuine possibility of needing to be repeated. If someone tells you they “had an ablation and it was nothing”, ask which arrhythmia.

Ablation is also used for frequent ventricular ectopic beats when the burden is high and symptoms intrusive, or when the ectopy is weakening the pumping muscle; the target is found by mapping the earliest point of activation, and difficulty depends on where that turns out to be. Ablation for ventricular tachycardia in a scarred heart is a different undertaking again, described in the section on ventricular tachycardia.

Who it is for, and the misunderstanding that matters most

AF ablation is offered principally to relieve symptoms — for people whose AF continues to affect their life despite medication, for those who cannot tolerate antiarrhythmic drugs, and increasingly as an earlier option in younger people with paroxysmal AF, where the atrium is less remodelled and the result more durable. It is also considered in AF with impaired pump function, where restoring rhythm can improve the heart’s performance.

Now the point patients get wrong more often than any other, stated without hedging: ablation does not, by itself, mean anticoagulation stops. Anticoagulation is decided by your stroke risk profile, not by what your rhythm is doing this month, and AF that recurs silently after ablation carries the same risk as AF you can feel. Any change is a decision made by the doctor who prescribed it, after assessment, and often the answer is that it continues indefinitely. Having a procedure in order to come off tablets is the wrong reason to have one.

The risks of ablation

Ablation is a low-risk procedure in experienced hands, and it is not a trivial one. The complications you should hear about before consenting:

• Vascular access complications at the groin — bruising is near-universal, but a significant haematoma, a false aneurysm or an arteriovenous fistula can occur and occasionally needs repair. This is the most common problem by a distance.
• Cardiac tamponade — bleeding into the sac around the heart from a perforation, compressing the heart and requiring urgent drainage. Uncommon, recognised quickly, and the reason ablation is done where that drainage can be performed immediately.
• Stroke or transient ischaemic attack from clot or air introduced on the left side of the heart, minimised by anticoagulation during the procedure and careful catheter technique.
• Phrenic nerve injury, causing a temporarily or occasionally permanently paralysed diaphragm and breathlessness. Most associated with cryoballoon work near the right-sided veins, and monitored for throughout.
• Pulmonary vein stenosis — narrowing of a vein from ablation too close to its opening. Rare with modern technique.
• Atrio-oesophageal fistula — an abnormal connection between the back wall of the left atrium and the oesophagus, which lies immediately behind it. It is rare and it is catastrophic, and it characteristically appears not on the day but one to several weeks after the procedure, with fever, difficulty swallowing, chest pain or neurological symptoms.
• Radiation exposure from X-ray guidance, minimised by 3D mapping systems that let much of the work be done with the imaging switched off.

Recovery, the blanking period, and follow-up

Most people stay one night; some go home the same day after a simple ablation. You lie flat for a few hours to let the puncture sites seal. Groin discomfort and bruising are expected. Heavy lifting and vigorous exercise are avoided for several days, and most people are back to desk work within a week. Chest discomfort, a fast pulse and short runs of palpitations in the first weeks are common.

That last point has a name. The blanking period is the first three months after ablation, while the tissue is inflamed and healing and the rhythm is unstable. Recurrences during this window are common and do not mean the procedure has failed. Antiarrhythmic medication is often deliberately continued through it, then reviewed. An ablation is judged after the blanking period, not during it, and knowing that in advance saves a great deal of unnecessary despair in week six.

Follow-up involves rhythm monitoring rather than reliance on symptoms, a medication review by your prescriber, and continued attention to the drivers in the section on AF drivers, which do more to determine durability than the choice of catheter did. A repeat procedure is a realistic possibility in persistent AF and is planned rather than treated as a setback.

Stroke prevention in atrial fibrillation

This is the part of AF care that matters most and the part patients pay least attention to, because it treats a risk you cannot feel rather than a symptom you can. Restoring rhythm makes you feel better; preventing stroke protects your life and independence.

Why AF causes stroke. When the left atrium fibrillates instead of contracting, blood stagnates — most of all in a small, hooked, blind-ended pouch off the left atrium called the left atrial appendage, a cul-de-sac with a narrow mouth and a trabeculated interior, essentially built to let blood sit still. The overwhelming majority of clots that cause stroke in non-valvular AF form there. A clot that breaks free travels with the arterial flow, and a large share of that flow goes to the brain. AF-related strokes tend to be larger and more disabling than others, because the embolus is often big enough to block a major vessel. Care after a stroke sits with neurology; the point of this section is to make that referral unnecessary.

CHA2DS2-VASc: a tool for a conversation, not a verdict

Stroke risk is not the same for everyone with AF. It is estimated with the CHA2DS2-VASc score, which adds up clinical factors:

• C — congestive heart failure or impaired left ventricular function: 1 point
• H — hypertension: 1 point
• A2 — age 75 or over: 2 points
• D — diabetes: 1 point
• S2 — previous stroke, transient ischaemic attack or arterial thromboembolism: 2 points
• V — vascular disease: previous heart attack, peripheral arterial disease or aortic plaque: 1 point
• A — age 65 to 74: 1 point
• Sc — sex category, female: 1 point, treated as a risk modifier rather than a risk factor in its own right, so it rarely tips a decision alone

The clearest way to read it is to count the points other than sex. No other risk factors generally means no anticoagulation; one other risk factor is a genuine discussion; two or more, in either sex, is where anticoagulation is usually recommended, though the thresholds vary slightly between guidelines.

Read the score for what it is: a population-derived estimate that structures a conversation. It does not know how frail you are, whether you fall, or what you are willing to accept. Bleeding risk is weighed alongside it, using tools such as HAS-BLED, and here the intention is routinely misread — a high bleeding score is not a reason to withhold anticoagulation from someone who needs it. It is a prompt to find and fix the modifiable contributors: uncontrolled blood pressure, hazardous drinking, other drugs that add bleeding risk, unstable control. The decision weighs a stroke you might prevent against a bleed you might cause.

Anticoagulation: what “blood thinners” actually are

The phrase blood thinners for afib is imprecise and causes real harm, because it merges two different drug groups. Antiplatelets such as aspirin and clopidogrel make platelets less sticky and are the mainstay after coronary stents. Anticoagulants interrupt the clotting cascade itself and are what AF requires. They are not interchangeable.

Direct oral anticoagulants (DOACs) are the usual first choice in non-valvular AF. They are taken at a fixed dose without routine blood testing, act quickly, have far fewer food and drug interactions than warfarin, and specific reversal agents exist for serious bleeding or emergency surgery. The dose is adjusted for kidney function, age and weight, and kidney function is rechecked periodically because a dose that was right last year may not be right now. Their short duration of action is both an advantage and a trap — miss doses and protection falls away quickly.

Warfarin remains essential in specific situations, and in some it is the only appropriate option: mechanical heart valves and moderate-to-severe mitral stenosis, where DOACs are not suitable. It requires regular INR blood tests, its effect is altered by dietary vitamin K and by a long list of medicines and supplements, and keeping the INR in range is real work. In exchange it is well understood and readily reversible.

Some practical points apply to both, and none is optional. They are prescribed and monitored by your own doctor — nothing in this section is a reason to begin, change or discontinue anything.

Stopping an anticoagulant on your own initiative is dangerous. The protection disappears within days and stroke risk returns. That applies to stopping because of bruising, because you feel well, because your rhythm is back to normal, because you have had an ablation, or because a dentist, endoscopist or surgeon has mentioned it. Interruption before dental work, surgery or an invasive test is sometimes necessary and sometimes not — many dental procedures need none at all — and the plan for when to stop and when to restart comes from the doctor who prescribed it, in communication with whoever is doing the procedure. Ask them, in advance.

Aspirin is not adequate stroke prevention in atrial fibrillation. The misunderstanding is common, comfortable and dangerous. Aspirin offers little protection against the kind of clot that forms in a fibrillating atrium, while still carrying bleeding risk of its own. Anyone who believes a daily aspirin has them “covered” for AF should raise it at their next appointment rather than assume.

Left atrial appendage closure and the Watchman device

The left atrial appendage is a small, hooked, blind-ended pouch hanging off the left atrium — a leftover of how the chamber formed before birth, with a narrow mouth, a deep body and a ridged interior. In a normal rhythm it empties with every atrial contraction and nothing settles in it. In atrial fibrillation the atrium stops contracting, the pouch stops emptying, and blood sits still in exactly the shape of cul-de-sac that encourages clot to form. Nearly all the clots that cause stroke in non-valvular AF begin there, which is why stroke prevention in AF dominates the management of the condition.

That single anatomical fact produces an obvious idea: if almost all the danger comes from one pouch, close the pouch. Left atrial appendage closure does exactly that. A device is placed in the mouth of the appendage so that anything forming inside can no longer escape into the circulation. The Watchman implant is the most widely used and the name most people arrive with; Amulet and other designs work on the same principle. Closure does nothing to the rhythm itself — the AF continues, and the rate and symptom questions are managed as before.

Who the Watchman device is for

This needs stating plainly, because the marketing of any implant tends to blur it. Left atrial appendage closure exists for people who need stroke protection but cannot safely take anticoagulation for the long term. It is not an alternative for people who dislike taking tablets or hope to be finished with medication after an ablation. Where anticoagulation can be taken it remains the reference standard, and trading a tolerated tablet for a permanent implant is a poor bargain. Raise the question with your cardiologist by all means — but expect the answer to turn on your bleeding history rather than your preference.

The people for whom a Watchman is genuinely considered are those who have had serious or repeated bleeding while anticoagulated, those with a bleeding source that cannot be corrected, and those whose bleeding risk is judged unacceptable for reasons that will not change. Whether you need stroke protection at all is settled first, using the risk assessment described in stroke prevention in AF; closure is a question about how, never about whether.

The assessment beforehand is substantial. Your AF diagnosis and stroke risk are confirmed, and the bleeding problem is reviewed by the specialist who owns it — gastroenterology, haematology, neurology — because a correctable source should be corrected rather than worked around. Detailed imaging, usually a transoesophageal echocardiogram or a cardiac CT, maps the size, shape and lobes of your appendage, since devices are sized to individual anatomy and some shapes suit one design better than another. That scan also looks for clot already sitting in the pouch; if clot is found, the procedure is postponed rather than performed. Anaesthetic fitness, kidney function and your other cardiac plans all feed into a decision normally taken jointly rather than by one operator. The appendage is sometimes closed or removed surgically during a heart operation being done for another reason, which belongs with cardiovascular surgery.

How the device is implanted

Implantation is done through a vein, not through the chest. You fast beforehand, and the procedure takes place under general anaesthetic or deep sedation — partly for stillness, partly because the imaging probe used to guide it is not tolerated awake. A sheath goes into the femoral vein at the top of the leg, catheters are advanced to the right atrium, and the septum between the upper chambers is punctured to reach the left atrium: the same transseptal route used in catheter ablation.

Imaging governs every step. A transoesophageal echocardiogram, with the probe passed into the oesophagus directly behind the left atrium, or an intracardiac echo catheter inside the heart itself, is combined with X-ray screening and contrast. The appendage is measured again in theatre, the implant size chosen, and the device advanced folded inside its sheath and opened in the mouth of the pouch. Before release the operator checks position, checks the anchoring by tugging gently on it under imaging, and checks that no significant flow passes around the edges. A Watchman is fabric-covered, and over the following weeks your own tissue grows across that surface; it is this layer, not the device alone, that finally seals the appendage off.

The sheath is then removed, pressure applied at the groin, and you lie flat for a few hours. Most people stay one night and go home after a scan and a check of the access site.

Risks, recovery and what happens afterwards

Recovery is usually quick. Groin bruising is expected, a sore throat is common after a transoesophageal probe, and heavy lifting is avoided for several days. Most people are back to ordinary activity within a week.

Medication does not stop on the day of the implant, and this catches people out. Until your own tissue has covered it, the device is a foreign surface inside the left atrium on which clot can form. A defined period of anticoagulation, or of antiplatelet therapy, therefore follows every implantation — its length and composition decided by your team in light of the bleeding history that brought you there. Anyone considering closure precisely because they cannot take anticoagulants must have this discussed explicitly beforehand, since the regimen afterwards is close to the thing they were trying to escape. Nothing in that plan is adjusted, paused or stopped on your own initiative. The drug classes themselves belong to stroke prevention in AF.

Follow-up imaging — a transoesophageal echocardiogram or a cardiac CT at around six weeks, sometimes repeated later — confirms the appendage is sealed and that no clot has formed on the implant. It is the gate any reduction in medication passes through, and it is not optional.

The complications are specific and worth knowing before you consent. Pericardial effusion and tamponade — bleeding into the sac around the heart, compressing it — is the most significant procedural risk and can require urgent drainage or, rarely, surgery. Device-related thrombus can form on the implant, which is the whole reason follow-up imaging exists. A peri-device leak may persist where the seal is imperfect, and whether it matters depends on its size. Device embolisation, in which the implant dislodges and travels, is rare and serious, and may need retrieval or an operation. Vascular access problems at the groin — haematoma, false aneurysm, arteriovenous fistula — are the commonest minor complications, and stroke or air embolism can occur during the procedure itself.

Left atrial appendage closure versus staying on anticoagulation

Set side by side honestly, the two are not equivalent. Anticoagulation acts everywhere in the circulation; left atrial appendage closure addresses one pouch. Clot forming elsewhere — on a diseased or replaced valve, in the atrium outside the appendage, in the leg veins — is unaffected by a device, and closure is not appropriate at all in some situations where anticoagulation is mandatory. A tablet can be adjusted, interrupted for surgery or withdrawn; a Watchman is permanent, and removing one means cardiac surgery. Against that, for someone who has already bled badly the tablet is not a neutral option either, and continuing it can be the more dangerous course.

That is the real comparison: not device versus tablet in the abstract, but your own bleeding risk against your own stroke risk, with your anatomy and other conditions in the frame. It is also why nobody stops an anticoagulant in anticipation of closure, or on the strength of having been referred for it — the protection lapses long before any device is in place.

Pacemakers and implantable defibrillators

These two devices sit under the collarbone, look almost identical on a chest X-ray, and are routinely confused. The difference is fundamental, and getting it clear changes what you expect from the device.

A pacemaker treats a heart that beats too slowly. When a beat fails to arrive on time it delivers a small electrical impulse to make the heart contract, and most people are unaware of it happening. It cannot stop a dangerous fast rhythm, and it does not exist to.

An implantable cardioverter defibrillator, or ICD, exists to stop a lethal fast rhythm. It monitors continuously, and if it detects ventricular tachycardia or fibrillation it responds — first, where possible, with rapid pacing that most people do not feel, and if that fails, with a shock. A shock is felt. Every ICD also contains full pacemaker function, so an ICD does both jobs while a pacemaker does one. An ICD is implanted because someone has judged you to be at meaningful risk of sudden cardiac death — after a cardiac arrest, after sustained ventricular tachycardia, or in cardiomyopathy where the pumping function or the diagnosis itself puts you in a high-risk group. The pumping measurement itself, and the band at which this is formally considered, are set out under ejection fraction.

Single chamber, dual chamber and biventricular

The number of leads reflects what the device must coordinate. A single chamber device has one lead, usually in the right ventricle — used in permanent AF with a slow rate and in some ICD indications. A dual chamber device has leads in the right atrium and right ventricle, preserving the natural sequence of atrial then ventricular contraction, which most people with an intact atrial rhythm feel better with. A biventricular device adds a lead positioned to pace the left ventricle through a vein on its surface. This is cardiac resynchronisation therapy, and its purpose is different: it is not treating slowness at all, but re-coordinating a heart whose walls contract out of step because of a conduction delay, in selected people with heart failure. It comes as a pacemaker (CRT-P) or combined with a defibrillator (CRT-D).

Two variants deserve a sentence each. A leadless pacemaker is a self-contained capsule, smaller than a AAA battery, delivered through a vein in the leg and fixed inside the right ventricle — no chest incision, no pocket, no leads to fracture, at the cost of more limited pacing options. A subcutaneous ICD places its lead under the skin alongside the breastbone rather than inside the heart, avoiding vascular and lead problems entirely; it can deliver a life-saving shock but cannot pace for slowness or deliver antitachycardia pacing, so it suits people who need shock protection and nothing else.

The implant, and the first weeks

Implantation is done under local anaesthetic with sedation, typically taking an hour or two. A small incision is made below the collarbone, the leads are advanced through a vein into the heart under X-ray guidance and tested for position and electrical performance, and the generator is placed in a pocket under the skin or muscle. Most people go home the next day after a chest X-ray and a device check.

The first weeks are about letting the leads settle and the wound heal. You will be told not to raise that arm above shoulder height, and not to lift or pull heavily with it, for around four to six weeks — the single most important instruction, because leads displace most easily before scar tissue anchors them. Do not keep the arm immobile in a sling either; gentle everyday movement below shoulder height prevents a stiff shoulder. Keep the wound dry until told otherwise, and report increasing redness, swelling, discharge or fever to the implanting team promptly rather than waiting it out. A visible lump under the skin is normal and becomes less noticeable over months.

Driving. Restrictions after implantation are real; they differ between a pacemaker and an ICD, differ again if the ICD followed a cardiac arrest, and are longer for vocational licences. They are set by your own licensing authority, not by your cardiologist and not by a web page. Ask before discharge, and get the answer that applies to your country and licence class.

Living with a device

Modern devices are far more robust against interference than their reputation suggests. Airport security: carry your device identification card, tell the staff, walk through the archway at a normal pace without pausing, and ask for a manual search rather than a handheld wand over the device. Mobile phones: keep the handset to the opposite ear and out of a breast pocket over the device. Induction hobs, most power tools and domestic appliances are fine at ordinary working distance. Shop anti-theft gates: walk through, do not linger. Arc welding, industrial magnets and some medical equipment including diathermy do need specific advice — always tell any clinician, including your dentist, that you have a device.

MRI. The old blanket ban is gone. Most contemporary devices and leads are MRI conditional, meaning a scan can be performed safely provided specific conditions are met, including reprogramming before and after. It is not automatic, it depends on your exact device and lead combination, and it is arranged with your cardiology and imaging teams together rather than turning up and hoping.

If your ICD delivers a shock, it fired because it detected a rhythm it judged life-threatening. The device stores a complete recording of what it saw and did, so the reason can be established precisely afterwards, including whether the shock was appropriate or triggered by something else. If someone is touching you when a shock is delivered they may feel a mild tingle; it is not dangerous to them, and not a reason to let go of someone who needs help.

Risks, generator replacement and remote monitoring

The complications worth knowing: infection, of the pocket or spreading to the leads and bloodstream, the most serious device complication and one that often requires the entire system to be removed rather than treated with antibiotics alone; lead displacement in the early weeks, or lead fracture and insulation failure years later, either of which can make the device work unreliably or, in an ICD, deliver an inappropriate shock; pneumothorax, air in the chest cavity from the needle used to access the vein, sometimes needing a drain; pocket haematoma, more likely on anticoagulation; narrowing of the vein the leads pass through, over years; and worsening tricuspid valve leakage from a lead crossing the valve. Inappropriate shocks triggered by fast AF or lead noise rather than a dangerous rhythm are distressing, and preventing them is much of what programming and remote monitoring are for.

Batteries are not rechargeable and not replaceable on their own. When the generator approaches end of life — several years to well over a decade, depending on the device and how hard it works — it is replaced in a shorter procedure reusing the existing leads where they still perform well. You will have plenty of warning; devices signal depletion long before it matters.

Remote monitoring has changed follow-up more than any hardware development. A bedside transmitter or phone application sends device data automatically, so lead problems, battery status, arrhythmia episodes and shocks reach the clinic without you attending. That means fewer routine visits, earlier detection of problems and, for many people, the discovery of silent atrial fibrillation episodes the device recorded and they never felt. It does not replace emergency care and it is not watched minute by minute.

Other arrhythmias: SVT, heart block, long QT and ventricular tachycardia

Not every rhythm disturbance is atrial fibrillation, and several of the others behave differently enough that grouping them would mislead. What follows separates the ones patients most often encounter, in ascending order of seriousness.

Supraventricular tachycardia

SVT is a fast, regular rhythm arising above the ventricles. The commonest forms are re-entrant: an impulse finds a circular pathway and circles it, hundreds of times a minute, until something interrupts it. In AV nodal re-entrant tachycardia the circuit sits inside the AV node itself. In AV re-entrant tachycardia it uses an extra electrical connection between atrium and ventricle present since birth — an accessory pathway, which when visible on a resting ECG is called Wolff-Parkinson-White.

The clinical signature is abruptness. SVT starts from nothing in a single beat — patients describe a switch being flipped — runs at a steady fast rate, and stops just as suddenly, after minutes or hours. There is often a pounding sensation in the neck, sometimes light-headedness, and characteristically a need to pass a lot of urine shortly after it stops. In an otherwise normal heart SVT is frightening rather than life-threatening, and it often begins in young adulthood, which is why it is so frequently attributed to anxiety for years before anyone records it.

Vagal manoeuvres — bearing down, the modified Valsalva with the legs raised, a cold stimulus to the face — can terminate an episode by increasing vagal tone and interrupting the circuit. They should be taught to you in person by a clinician who has confirmed what your rhythm actually is, not copied from a description online; carotid sinus massage and eyeball pressure, both of which circulate on the internet, should not be self-administered at all. If an episode does not stop, hospital treatment uses intravenous drugs under continuous monitoring that interrupt conduction through the AV node and terminate the rhythm within seconds, or a synchronised shock if you are unwell with it.

The message about SVT is an optimistic one. Because the circuit is small, fixed and identifiable, catheter ablation is often curative for the common re-entrant forms and is a considerably simpler procedure than AF ablation. Many people who have spent years arranging their lives around unpredictable episodes have one procedure and are finished with it. Accessory pathways carry an extra consideration: if atrial fibrillation occurs in someone with a rapidly conducting pathway, the ventricles can be driven dangerously fast, and that possibility lowers the threshold for treating a pathway even when symptoms are mild.

Bradycardia and heart block

A slow heart rate is not automatically a problem: fit people, and most people while asleep, run slow rates with no consequence. Bradycardia matters when it produces symptoms — fatigue, breathlessness on exertion, light-headedness, confusion in older people, blackouts — or when the underlying conduction disease is of a type known to progress. The commonest causes are age-related fibrosis of the conduction system, sinus node disease (the heart’s own pacemaker becoming unreliable, often alternating slow and fast rhythms), and medicines that slow conduction, including several used for AF and blood pressure. Where a drug is responsible, the answer is a review by the prescriber, not a unilateral stop.

Heart block means impulses are delayed or fail to pass from atria to ventricles, and the degrees are worth knowing because they carry very different weight:

• First-degree block: every impulse gets through, just slowly. Usually no symptoms and usually no treatment, though it is noted and watched.
• Second-degree, Mobitz type I (Wenckebach): conduction is delayed a little more each beat until one impulse fails altogether, then the cycle restarts. Often benign, common at night and in athletes.
• Second-degree, Mobitz type II: beats are dropped suddenly, without the progressive warning. This is structural disease of the conduction system below the node, it can progress without notice, and it is treated as significant even when symptoms are mild.
• Third-degree, or complete, heart block: nothing passes. The ventricles fall back on their own slow escape rhythm, independent of the atria. This causes marked symptoms and collapse, and is a clear indication for a device.

Mobitz II and complete heart block generally lead to a pacemaker. Terms such as bundle branch block, which appear on ECG reports and worry people considerably, are explained in the section on reading your ECG report; a conduction abnormality found there is interpreted in the context of the whole heart rather than treated as a diagnosis on its own.

Prolonged QT

The QT interval measures how long the ventricles take to recover electrically after each beat. When that recovery is abnormally prolonged, the heart becomes vulnerable in the recovery window to a chaotic ventricular rhythm called torsades de pointes, which can cause fainting and can degenerate into cardiac arrest. Prolonged QT therefore matters out of proportion to how innocuous the phrase sounds.

There are two routes to it. Congenital long QT syndrome is inherited, caused by variants in the genes encoding the ion channels that control repolarisation. It typically declares itself in childhood or young adulthood with fainting or seizure-like episodes, classically triggered by exertion, swimming, sudden loud noise or emotional stress depending on the subtype. It is diagnosed by a specialist using the ECG, family history, exercise testing and genetic testing, and it involves the whole family: first-degree relatives are screened.

Acquired QT prolongation is far more common, and the point people most need to know is that a considerable number of ordinary medicines prolong the QT interval. Certain antibiotics, antifungals, antipsychotics, antidepressants, anti-nausea drugs and antiarrhythmics all appear on the list, and the risk multiplies when two are combined or when potassium or magnesium is low. That is why an ECG is often done before and after starting particular drugs: it is measured rather than guessed. Tell every prescriber, including dentists and non-cardiac specialists, if you have been told your QT is long or there is a family history of it. And if you think a medicine you take is on that list, raise it with the doctor who prescribed it rather than stopping it yourself, because untreated infection, psychosis or arrhythmia carries its own hazard.

Ventricular tachycardia, and family history

Ventricular tachycardia belongs in a different category from the rhythms described earlier in this section. It arises in the ventricles themselves, so the pumping chambers are both generating the rhythm and failing to fill properly at speed. Short, self-terminating runs may cause nothing more than palpitations and are often found on a monitor. Sustained VT causes light-headedness, breathlessness, chest pain or collapse, and can deteriorate into ventricular fibrillation and cardiac arrest.

Most VT occurs in a heart that is already abnormal — scarred after a heart attack, or affected by cardiomyopathy — where the scar creates the slow-conducting channels the rhythm circles. A minority occurs in structurally normal hearts from a single irritable focus, and that form is generally far more benign and often very treatable by ablation. Which one you have is established with an echocardiogram, usually cardiac MRI to characterise scar, and assessment of the coronary arteries. Treatment may involve antiarrhythmic medication, ablation of the circuit, and in most people with sustained VT and structural heart disease an implantable defibrillator — because drugs and ablation treat the rhythm while the device protects against the consequence of it returning.

Finally, one part of the history changes an entire assessment: sudden unexplained death in a close relative at a young age — or a relative who drowned as a competent swimmer, died in an unexplained single-vehicle accident, or carried an epilepsy label that never quite behaved like epilepsy. Any of those raises the possibility of an inherited arrhythmia syndrome or heart muscle disorder in the family, and it turns an investigation of your palpitations from routine into detailed: ECG, echocardiogram, exercise testing, often cardiac MRI, and referral for genetic assessment with screening of first-degree relatives. Tell whoever is assessing you, unprompted, even if it happened decades ago and nobody ever explained it. The inherited muscle disorders behind many of these stories are described in the section on cardiomyopathy.

Heart valve disease and what a heart murmur means

A heart murmur is a sound, not a diagnosis. Blood moving through a healthy heart is fairly quiet. When it speeds up, changes direction, or squeezes past something narrow, the flow becomes turbulent, and turbulence makes a noise a doctor can hear through a stethoscope. The murmur tells your doctor that blood is moving in a way that deserves an explanation. On its own it does not tell anyone that something is wrong with your heart.

A great many murmurs are innocent — the medical word for a murmur made by normal blood moving through a normal heart. They are extremely common in children, whose chest walls are thin and whose hearts pump quickly, and most fade with growth. They are common in pregnancy, because blood volume and cardiac output both rise. Fever, anaemia, an overactive thyroid gland and athletic training do the same thing. If a doctor mentions a soft murmur at a routine check, that sentence by itself is not bad news.

Other murmurs are the first audible sign of a valve that is not working properly, and there is no reliable way to separate the two by listening alone. That is the honest position, and it is why the next step is almost always the same test.

When a murmur needs an echocardiogram

An echocardiogram settles the question. It shows each valve moving, measures how much blood gets through and how much goes backwards, and shows what the muscle has done in response. That report is the document that matters, and the wording it uses to describe severity is explained where the scan itself is explained. Reasons your doctor will want it rather than simple reassurance:

• A murmur that is new in an adult, or louder than at the last examination.
• A murmur with symptoms: breathlessness on exertion, chest tightness, dizziness, fainting, swollen ankles, or a drop in what you can do without stopping.
• A loud or harsh murmur, one felt as a vibration through the chest wall, or one heard while the heart is relaxing rather than contracting.
• A murmur alongside an abnormal ECG, an abnormal heart sound, or an enlarged heart on a chest X-ray.
• A murmur in someone with a known bicuspid aortic valve, previous rheumatic fever, a previous valve operation, a connective tissue disorder, or a close relative with valve disease.
• Any murmur in a baby who feeds poorly, breathes fast, fails to gain weight or looks dusky.

Four valves, two ways they go wrong

Each of the heart’s four valves is a one-way door. The mitral and aortic valves sit on the left and handle blood at high pressure on its way out to the body. The tricuspid and pulmonary valves sit on the right and work at much lower pressure. Because the left side works against so much more resistance, left-sided valves are the ones that most often need treatment in adults.

Whatever the valve, only two things can go wrong. It can fail to open fully — stenosis, or narrowing, so the heart must generate more force to push the same blood through. Or it can fail to close fully — regurgitation, or leaking, so blood goes backwards each beat and the heart handles it twice. One valve can do both. Stenosis loads the heart with pressure and the muscle thickens; regurgitation loads it with volume and the chamber stretches, which is why the two are followed with different measurements and treated on different timelines. The usual causes in adults are age-related calcification, a valve born with an abnormal number of leaflets, previous rheumatic fever, infection of the valve, connective tissue disorders, and stretching of a valve ring because the chamber behind it has enlarged.

Why valve disease is silent for years, and then is not

The heart compensates well. Faced with a narrowed valve it thickens its wall; faced with a leaking one it enlarges the chamber. Compensation works, so you feel normal, and meanwhile you quietly adjust — you take the lift, you stop carrying the shopping up in one trip, you garden for twenty minutes instead of an hour. Most people register that as getting older rather than as a symptom. Then compensation reaches its ceiling and symptoms appear over months, by which time the muscle may already have changed in ways that do not fully reverse. That is why valve disease is followed with scans rather than with how you feel, and why the question worth answering honestly is: what can you do now that you could not do last year?

One symptom is not for observing. Fainting while exercising is a different event from fainting at the sight of a needle, and in someone with a valve problem it is among the most important warnings there is.

What decides the timing of treatment

People expect a single number to trigger intervention. It does not work that way. Three things are read together, and any one can move the decision: symptoms, whose genuine appearance on exertion is the most powerful single factor; severity on imaging, measured several ways and cross-checked because one measurement can mislead; and what the ventricle has done — whether the pumping chamber has begun to enlarge or weaken, which can justify treating someone who says they feel fine. That last measurement is explained under ejection fraction. Pressure in the lung circulation, the arrival of atrial fibrillation, whether another cardiac problem needs treating at the same time, and your other conditions all enter the same discussion. The thresholds differ by valve and belong with aortic stenosis and mitral regurgitation.

Watchful waiting is a plan, not a delay

Being told your valve does not need treating yet is a management decision, and a proper one comes with three things attached: a date, a test, and a list. The date is your next echocardiogram. The test is the same scan repeated so images can be compared like for like. The list is the symptoms that mean you come back sooner. Typical intervals run roughly like this — mild disease reviewed every two to three years, moderate about once a year, severe without symptoms every six months or sooner — but those are conventions, and yours depends on your valve, your measurements and how much has changed between scans. If nobody books the next appointment before you leave, ask for it. Surveillance that exists only as an intention is not surveillance. Two practical points belong with any valve diagnosis: keep your teeth and gums in good order and tell your dentist about the valve, and report an unexplained fever lasting more than a week to your doctor rather than treating it at home as a lingering virus.

Aortic stenosis and TAVI (TAVR): when a narrowed valve needs replacing

Aortic stenosis is narrowing of the valve between the left ventricle and the aorta — the door through which every heartbeat sends blood to the rest of your body. As the valve stiffens and its opening shrinks, the ventricle must generate more pressure to push the same blood through. The muscle thickens to manage it, and for a long time it succeeds.

The common form is calcific aortic stenosis, which becomes more frequent with each decade of life. Calling it wear and tear undersells it: the process looks like an active biological one — injury to the valve surface, lipid deposition, inflammation, then progressive calcification — which is why it shares risk factors with arterial disease. It remains a mechanical problem, and no medication has been shown to make a narrowed valve open again.

A bicuspid aortic valve is a different story with the same ending. Instead of three leaflets you were born with two, or with three partly fused. It is one of the commonest congenital cardiac variations, it often runs in families, and the abnormal mechanics accelerate calcification — so bicuspid valves tend to narrow significantly in the fifties or sixties rather than the eighties. They also carry a higher chance of dilation of the aorta, which is followed on imaging in its own right, and it is why first-degree relatives are often offered a screening echocardiogram.

The three symptoms, and why their arrival changes everything

Severe aortic stenosis has a classic triad, and all of it appears on exertion first: breathlessness on effort, or a fall in exercise capacity you have unconsciously worked around; chest tightness or pressure on effort, which feels like angina even when the coronary arteries are clean, because a thickened muscle working against a narrow valve outstrips its own blood supply; and dizziness, near-fainting or fainting during exertion, because the narrowed valve cannot increase output to match demand.

Here is the part that matters most. For years, severe aortic stenosis can be a slow, watchable condition. The moment symptoms genuinely begin, it stops being slow. The onset of symptoms is the point at which the disease changes character, treatment is discussed without delay, and watchful waiting is no longer the right plan. It is also why cardiologists press so hard on exercise tolerance, and why an exercise test is sometimes used in people who insist they have no symptoms — to find out what happens when they are made to work.

How severity is judged

Severity is graded on the echocardiogram, using several measurements read together rather than any one alone: how fast blood jets through the valve, the pressure difference the ventricle must generate across it, and the calculated area of the opening. Those should agree. When they do not, the discrepancy is informative — a weak or small ventricle can push so little blood that the pressure difference looks reassuring while the valve is severely narrowed. That situation is worked up further, sometimes with a stress echocardiogram, sometimes with a CT measurement of calcium in the valve itself, which is a different test from the coronary calcium score. Grading also does not map neatly onto how you feel: some people have severe stenosis on paper and genuinely no symptoms, and some have moderate disease with breathlessness caused mostly by something else. The report is a signal to be interpreted alongside you, not a verdict on its own.

TAVI or surgery: a heart team decision

Once treatment is indicated there are two established ways to replace the valve, and the choice is made by a heart team — interventional cardiologists, cardiac surgeons, imaging specialists and anaesthetists looking at the same case together. If you are offered one option without the other being discussed, that is a fair thing to question.

Surgical aortic valve replacement replaces the valve through an operation on the open heart, with a mechanical or tissue prosthesis, and remains the reference treatment in younger patients, in bicuspid anatomy unsuitable for a catheter valve, and where the aorta or another cardiac problem needs attention at the same time. It is described where it belongs, with cardiovascular surgery.

TAVI — transcatheter aortic valve implantation, written TAVR (transcatheter aortic valve replacement) in North America, and the same operation either way — places a new valve inside the old one through a catheter, without opening the chest. What pushes the discussion one way or the other is age and expected valve durability, the anatomy on the planning CT, frailty and other illnesses, previous cardiac surgery, and whether anything else needs fixing at the same time. Being older or less fit tends to favour a catheter approach; being younger, with decades of valve life ahead, tends to favour surgery. There is a broad middle ground where both are reasonable and your own priorities legitimately count.

What a TAVI involves

Planning comes first: a dedicated CT of the heart and of the arteries from the groin upwards, which decides valve size and access route. In most cases the route is the femoral artery in the groin, entered through a puncture rather than a cut; where those vessels are too small, calcified or tortuous, the subclavian or carotid artery, or the aorta directly, are used instead.

A collapsed replacement valve mounted on a metal frame is advanced up to the diseased valve and deployed inside it, pushing the old calcified leaflets aside and taking over their job immediately, guided by live X-ray imaging and often by ultrasound from within the oesophagus. Many procedures are done under sedation with local anaesthetic at the access site, with the patient awake or lightly asleep, which is part of why recovery is quicker; general anaesthetic is still used where the case requires it. Afterwards you are monitored closely, with particular attention to heart rhythm and to the puncture site. Hospital stay is typically measured in days rather than weeks, and walking usually starts the day after. Antiplatelet or anticoagulant medication is prescribed according to your circumstances and monitored by your own doctor — and if you are on an anticoagulant, stopping it on your own initiative is dangerous and must never be done without the doctor who prescribed it.

The risks of TAVI

TAVI is a real cardiac intervention and it carries real risks. These belong in the consent conversation before the date is booked, not afterwards.

• Stroke. Manipulating catheters across a heavily calcified valve can dislodge debris. It is uncommon, and it is genuine.
• The need for a permanent pacemaker. The conduction system runs immediately beneath the aortic valve and the new frame can press on it. This happens often enough that it must be discussed in advance: some people leave hospital with a permanent pacemaker they did not have on arrival. Certain valve designs and anatomies carry more of this risk, and it is reasonable to ask about your own case.
• Vascular access complications — bleeding, damage to the femoral artery, or a false aneurysm at the puncture site, occasionally needing a further procedure or surgical repair.
• Paravalvular leak — blood escaping around the outside of the frame rather than through the valve. Small leaks are common and often inconsequential; larger ones matter and are addressed at the time where possible.
• Kidney effects from contrast, which is why kidney function is checked before and after and hydration is planned in advance.
• Rarer but serious events: the valve moving out of position, injury to the valve ring, blockage of a coronary artery, bleeding around the heart, or infection of the new valve later.
• Long-term durability, the genuinely open question. Catheter valves are made of tissue, and tissue valves do not last forever. Nobody can yet tell a person in their sixties with certainty how a catheter valve will behave in their eighties. That uncertainty is exactly why age weighs so heavily in the heart team discussion, and why the plan for a worn-out valve — a second valve placed inside the first, or surgery — is worth asking about at the outset.

Balloon valvuloplasty

Balloon aortic valvuloplasty stretches the narrowed valve open with a balloon on a catheter. In adults it is not a treatment, because the valve renarrows within months. It has two legitimate uses: stabilising someone acutely unwell so a proper decision can be made, and testing whether opening the valve genuinely improves symptoms in someone whose breathlessness might be coming from their lungs. Offered as a definitive answer to aortic stenosis in an adult, it is the wrong procedure.

Mitral valve regurgitation and MitraClip

Mitral valve regurgitation means the valve between the left atrium and the left ventricle does not seal when the ventricle contracts, so some blood is pushed backwards into the atrium instead of forwards into the body. The heart compensates by moving a larger volume with each beat, and over years that extra volume stretches both chambers. Before anything else, the distinction patients are most often not told about — the one that changes the entire treatment plan.

	Primary (degenerative)	Secondary (functional)
What is wrong	The valve apparatus itself — leaflets, the cords tethering them, or the ring	The valve is essentially normal; the ventricle or atrium has enlarged and pulled it out of shape
Typical causes	Mitral valve prolapse, a ruptured cord, rheumatic disease, endocarditis, calcification of the ring	A previous heart attack, dilated cardiomyopathy, long-standing atrial fibrillation stretching the atrium
What treating the valve achieves	Fixing the valve fixes the problem	Fixing the leak does not fix the ventricle; the underlying disease continues
First line of treatment	Surveillance, then repair when criteria are met	Full medical and device treatment for heart failure first, with valve intervention considered only if symptoms persist

That is why two people with the same phrase in their echo report can be given completely different advice. In primary disease the valve is the disease. In secondary disease the leak is a consequence, and treating it in isolation without treating the ventricle rarely helps for long.

Mitral valve prolapse

Mitral valve prolapse means one or both leaflets bulge back into the atrium as the heart contracts. It is common, often found by accident on a scan done for something else, and in the large majority of people it never progresses to anything needing treatment: no leak or a trivial one, no restrictions, no medication. A minority develop significant regurgitation over time, particularly where the leaflets are thickened and redundant, and a small number develop a sudden severe leak when one of the fine cords tethering a leaflet ruptures. That is why prolapse earns follow-up rather than dismissal, and why the interval is set by how the valve looks rather than by how you feel. Palpitations and atypical chest discomfort reported alongside prolapse are assessed on their own merits, under palpitations.

Symptoms and the silent phase

Chronic mitral regurgitation is quiet for a long time. Symptoms, when they come, are breathlessness on exertion, tiredness, a fall in exercise capacity, palpitations, and eventually breathlessness lying flat or swollen ankles. Atrial fibrillation often appears as the left atrium stretches, and its arrival is a meaningful event rather than an incidental one.

Because the heart absorbs the extra volume so well, the ventricle can begin to enlarge and weaken before you notice anything. That is the whole justification for surveillance echocardiograms in the silent phase: the scan is looking for the point at which the heart starts to lose ground, which arrives before the symptoms do. Missing it is what turns a repairable valve into a repaired valve on a heart that never fully recovers.

Sudden severe regurgitation behaves completely differently. When a cord ruptures, a valve is destroyed by infection, or a heart attack damages the supporting muscle, the leak appears in hours and the atrium has had no time to adapt.

Treatment: repair, and the catheter alternative

For severe primary regurgitation, surgical repair of the valve is the reference treatment, and repair is preferred over replacement wherever the anatomy allows it, because a repaired native valve behaves better in the long run than a prosthesis. That operation sits with cardiovascular surgery. What belongs here is the timing, which uses the same three-part logic as any valve — symptoms, severity, and what the ventricle and atrium have done — set out under heart valve disease.

Transcatheter edge-to-edge repair, widely known by the device name MitraClip, is the catheter option. A catheter is passed from a vein in the groin to the right atrium, across the wall between the atria, and into the left side of the heart. A small clip grasps the two mitral leaflets where they fail to meet and holds them together, so one leaking opening becomes two smaller, better-sealing ones. It is done under general anaesthetic with continuous ultrasound guidance from within the oesophagus, and hospital stay is usually short.

It suits people with severe primary regurgitation who are symptomatic but poor surgical candidates because of age, frailty or other serious illness; and selected people with severe secondary regurgitation who remain symptomatic despite genuinely optimised heart failure treatment including devices, and whose ventricle size and leak severity fall in the range where the treatment has been shown to help. Not everyone with a functional leak benefits, and being turned down is a clinical judgement rather than a rationing decision. Anatomy matters as much as diagnosis: the leaflets must be graspable, the valve must not already be narrowed, and the leak must arise where a clip can reach.

It reliably reduces the leak and, in the right patient, improves breathlessness and what you can do. It usually does not abolish the leak — residual regurgitation is expected and accepted. It does not repair the ventricle, so in secondary disease the underlying heart failure and all its treatment continue unchanged. And it does not keep every future option open: surgery on a valve that already carries a clip is more difficult. The risks are those of a structural catheter procedure — bleeding and vascular injury at the groin, bleeding around the heart from the puncture between the atria, stroke, narrowing of the mitral valve if the clip restricts the opening too much, the clip detaching from one leaflet, damage to a leaflet, arrhythmia, and infection.

Mitral stenosis and rheumatic disease

Mitral stenosis — narrowing rather than leaking — is overwhelmingly a consequence of rheumatic fever after untreated streptococcal throat infection in childhood. It remains common in many parts of the world and typically declares itself decades later; a separate, slower form occurs in older people from heavy calcification of the mitral ring. Blood struggles to get from the atrium into the ventricle, pressure backs up into the lungs, and the atrium enlarges. Symptoms are breathlessness on exertion and then at rest, fatigue, coughing up blood-streaked sputum in advanced disease, and very commonly atrial fibrillation. Pregnancy, with its rise in blood volume and heart rate, frequently unmasks mitral stenosis that was previously silent, so any woman with known rheumatic valve disease planning a pregnancy should be assessed before conceiving rather than during.

Percutaneous balloon mitral valvuloplasty is, in this condition, a genuinely effective catheter treatment rather than a temporary measure — quite unlike its role in aortic stenosis. A balloon is passed across the atrial septum and inflated in the narrowed valve to split the fused edges. It suits pliable, minimally calcified valves with little regurgitation and no clot in the left atrium, which is why an ultrasound from within the oesophagus is done first to look for one. Where the anatomy is unfavourable, surgery is the route.

Atrial fibrillation with rheumatic mitral stenosis carries a high risk of clot forming in the left atrium, and anticoagulation is standard in that combination. That decision is made differently from the usual assessment described under stroke prevention in atrial fibrillation, and it is made by your own doctor. What applies to everyone: an anticoagulant is prescribed, timed and monitored, and stopping one on your own — because of a nosebleed, before a dental appointment, or because you feel well — is dangerous. Any change comes from the doctor who prescribed it.

Structural heart closures: PFO, ASD and related defects

Some of the commonest structural findings in adult cardiology are holes and channels between the two sides of the heart. They are not the same thing, they do not all need treating, and the difference matters — because one of them is present in a large minority of entirely healthy people.

Patent foramen ovale: a normal remnant, not a fault

Before birth your lungs are not in use, so blood is routed past them through a flap-like opening between the two atria called the foramen ovale. At birth the lungs inflate, pressures change, and the flap is pressed shut; in most people it fuses over the following months. In a large minority of perfectly healthy adults it never fuses completely, leaving a potential channel that can open briefly when pressure in the right atrium rises — during a cough, a strain, or lifting something heavy. That is a patent foramen ovale, or PFO.

Three things follow, and they are the points most often lost. A PFO is a normal developmental remnant, not a hole that has gone wrong — not a birth defect, and not something that has recently happened to you. The overwhelming majority of people with one live an entire life without it causing a problem, and most never know they have it. And finding a PFO is not, in itself, a reason to close it: it is frequently discovered incidentally on an echocardiogram with a bubble study done for another purpose, and the correct response in someone with no relevant history is an explanation, not a procedure. PFO has been linked in the public mind to migraine with aura; the association is real in the sense that PFO is more common in people with aura, but closing one to treat migraine is not supported by the evidence and is not an accepted indication.

When PFO closure is considered

One situation genuinely earns the discussion: a stroke with no other explanation in a younger adult. The reasoning is that a clot formed in a leg or pelvic vein, which the lungs would normally filter harmlessly, crossed to the left side of the heart through the PFO and travelled to the brain — a paradoxical embolism.

That conclusion is reached only after a thorough search for every other cause comes back empty: imaging of the neck and brain arteries, prolonged rhythm monitoring to exclude silent atrial fibrillation (see monitors), tests for clotting disorders, and assessment of the usual vascular risk factors. The decision is then made jointly by cardiology and neurology, using formal criteria that weigh your age, the absence of other risk factors, and the anatomy of the PFO itself — how large the shunt is, whether the atrial septum is aneurysmal — to judge how likely it is that the PFO was actually to blame rather than merely present. Closure is offered where that likelihood is high and the person is young enough for the long-term benefit to outweigh the procedure. Where it is low, medical treatment alone is the better answer. A narrower second situation is decompression illness in divers with a large shunt.

Atrial septal defect: a genuine hole

An atrial septal defect is a different thing altogether: a true deficiency in the wall between the atria, tissue that should be there and is not. Unlike a PFO, which is a flap that opens under pressure, an ASD is permanently open, and blood flows continuously from the higher-pressure left atrium into the right. The consequence is volume overload of the right side of the heart. Year after year the right atrium and right ventricle handle more blood than they should, and they dilate; over decades this can produce raised pressure in the lung circulation, atrial arrhythmias and right heart failure, and it can allow a clot from a vein to cross into the arterial circulation.

ASDs frequently go undetected into adulthood because the symptoms are so unremarkable: more breathless on the stairs than your friends, tiring easily, chest infections that linger. People put it down to age or fitness, and often no murmur is loud enough to prompt a scan. What leads to diagnosis in an adult is a dilated right ventricle seen on an echocardiogram done for another reason, a persistently split second heart sound, new atrial fibrillation or flutter in middle age, an unexplained stroke, or a characteristic pattern on the ECG. Whether an ASD needs closing depends on how much extra flow the right heart is carrying and what it has done to the right ventricle, not on the diameter of the hole alone. Not every ASD suits a catheter: the secundum type, in the middle of the septum with a rim of tissue all around it, is the one a device can close, while defects near the valves or near where the great veins enter the heart need surgical repair.

Device closure through a catheter

The procedure is done through a vein in the groin, so there is no incision in the chest. A closure device — typically two self-expanding discs joined by a waist — is advanced folded inside a catheter, opened on the far side of the defect, drawn back so the discs sandwich the septum, and released once position and stability are confirmed. Guidance comes from ultrasound taken either from within the oesophagus, which requires general anaesthetic, or from a catheter inside the heart itself, which allows sedation instead. Most people stay overnight and go home the next day with a small dressing at the groin.

Over the following months the device is covered by the heart’s own lining, becoming part of the septum rather than an object sitting in it. During that period you will be prescribed antiplatelet medication — usually for around six months, sometimes with a second agent for part of it — and given advice on antibiotic cover for dental work for a similar period. Strenuous activity and contact sport are restricted briefly, and a follow-up scan confirms the device is where it should be. The risks are small but not nil, which is why the indication has to be right:

• Device embolisation — the device moving from its position, which may need retrieval by catheter or, occasionally, surgery.
• Erosion — rare, but the most serious complication, where the device wears against the wall of the heart or the aorta and causes bleeding into the sac around the heart. It usually presents early with sudden chest pain, breathlessness or collapse.
• Atrial arrhythmia in the weeks after implantation, often self-limiting but sometimes needing treatment.
• Residual shunt, a small amount of persisting flow, which frequently disappears as the device is covered over.
• Clot forming on the device, vascular access complications at the groin, and rarely a reaction to the metal alloy used.

Because these closures are done to prevent a stroke, the symptoms of stroke are worth knowing exactly: sudden weakness or numbness of the face, arm or leg, especially on one side; sudden difficulty speaking or understanding; sudden loss of vision; sudden severe unsteadiness.

Ventricular septal defect and patent ductus arteriosus

A ventricular septal defect is a hole between the two pumping chambers; most are found in infancy, many small ones close by themselves or never need treatment, and those carrying significant flow are closed by surgery or, in selected positions, by a device. A patent ductus arteriosus is a fetal vessel between the aorta and the pulmonary artery that should close after birth; when it persists it is now usually closed with a device delivered by catheter.

Heart failure

The name is the worst thing about the diagnosis. Heart failure does not mean your heart has failed, is failing, or is about to stop. It means the heart is not keeping up with what your body asks of it — either because the muscle cannot pump strongly enough, or because it cannot relax and fill properly between beats. It is a chronic condition that is managed, often for many years. That distinction is worth making before anything else, because a great deal of unnecessary fear is created in the ten minutes after someone first hears the phrase.

What it feels like

The symptoms come from two things: not enough blood delivered forwards, and fluid backing up behind the heart.

• Breathlessness on exertion, then on less and less exertion. The useful question is not whether you are breathless but what you can no longer do.
• Breathlessness lying flat, so you use more pillows or end up sleeping in a chair, and waking at night gasping for air. That second symptom is quite specific and should always be mentioned.
• Swelling of the ankles and legs, and in more advanced cases the abdomen, with clothes and shoes becoming tight.
• Weight gain over days — fluid, not fat. Several kilograms in a week is a fluid problem, not a dietary one.
• Fatigue out of proportion to what you have done, reduced appetite, feeling full quickly, sometimes a dry night-time cough.

Two forms, not one disease with degrees

Heart failure with reduced ejection fraction means the muscle contracts weakly. The commonest causes are damage from a previous heart attack, cardiomyopathy, long-standing valve disease and long-standing arrhythmia. It has the largest and oldest evidence base, and treatment can improve both symptoms and the underlying function of the muscle.

Heart failure with preserved ejection fraction — HFpEF — means the muscle squeezes normally but has become stiff, so the ventricle does not fill easily and pressure rises behind it. It is strongly associated with age, high blood pressure, obesity, diabetes, atrial fibrillation, kidney disease and sleep apnoea. For years it was treated as a milder or less real version of the other form. It is not. It is its own disease, it produces just as much breathlessness and just as many hospital admissions, and it now has its own evidence-based treatment. Being told your pumping function is normal and being told nothing is wrong are two different sentences, and people with HFpEF are too often given the first and hear the second. The measurement itself is explained under ejection fraction.

How it is diagnosed

The BNP test — measuring BNP or NT-proBNP in a blood sample — is best understood as a rule-out test. These substances are released by heart muscle under stretch. A low result in someone not yet treated makes heart failure a very unlikely explanation for their breathlessness, which is genuinely useful, because it redirects the investigation towards the lungs, anaemia, thyroid disease or deconditioning. A raised result is a much weaker statement: increasing age, impaired kidney function, atrial fibrillation, infection, pulmonary embolism, strain on the right side of the heart and severe illness of almost any kind all raise it, while obesity pushes it down, so someone with a large body mass can have heart failure with a deceptively modest result. A raised BNP is a signal that the heart deserves a proper look, not a diagnosis in itself, and the laboratory’s cut-offs vary by assay and by age band.

The echocardiogram is the test that defines the diagnosis: pumping function, how the ventricle fills, chamber sizes, every valve, and an estimate of pressure in the lung circulation. From there the work turns to finding the cause, because that determines treatment — assessment of the coronary arteries where ischaemic damage is suspected, rhythm monitoring, blood pressure history, thyroid and iron studies, alcohol history, previous chemotherapy, and cardiac MRI where the muscle itself is in question (see technology). Iron deficiency deserves naming: it is common in heart failure, it makes symptoms considerably worse, and it is correctable.

Treatment

Modern treatment of heart failure with reduced ejection fraction is built on four medication classes used together, usually described as the four-pillar approach. Naming the classes helps you recognise your own prescription; the choice, the sequence, the dose and the monitoring belong entirely to the doctor treating you.

• An angiotensin receptor-neprilysin inhibitor, or an ACE inhibitor or angiotensin receptor blocker.
• A beta blocker, introduced at a low dose and increased slowly.
• A mineralocorticoid receptor antagonist.
• An SGLT2 inhibitor, which came from diabetes care and turned out to help in heart failure whether or not you have diabetes.

Alongside these, diuretics treat congestion — they relieve breathlessness and swelling and make you feel better fastest, but they act on the symptom rather than the disease. For HFpEF, treatment centres on SGLT2 inhibitors, diuretics for fluid, and determined treatment of the drivers: blood pressure, weight, atrial fibrillation, sleep apnoea and diabetes.

Two points about medication matter more than any list. First, these drugs are introduced gradually and increased over weeks, with blood tests for kidney function and potassium along the way; a small, expected change in kidney numbers is not a reason for alarm and is interpreted by the person who ordered the test. Second, without exception: do not start, stop, change or adjust any of these medicines yourself. Some teams give patients a written plan for what to do if their weight rises — if you have one, it came from your team and applies to you. Nothing you read online substitutes for it.

Some people also need a device. Cardiac resynchronisation therapy coordinates the two ventricles when electrical conduction is delayed, and an implantable defibrillator is considered where the risk of a dangerous rhythm is high; both are covered under pacemakers and ICDs. For a small number of people whose disease progresses despite everything, advanced options are assessed by a specialist team.

The self-monitoring that genuinely helps

Daily weight is the most useful thing you can do at home, because fluid arrives before symptoms do. Weigh yourself at the same time each morning, after using the toilet, before breakfast, in similar clothing, on the same scales, and write it down. A gain of around two kilograms over two or three days is the trigger many teams use for making contact — but the figure that applies to you is the one your own team gives you.

Salt and fluid advice should come from your team as well. Blanket fluid restriction is not right for everyone and can do harm in some situations, which is why the internet is a poor source for it. Reducing added salt and processed food helps most people, and dietetic support is worth asking for rather than improvising. Supervised cardiac rehabilitation improves symptoms and confidence — exercise in heart failure is prescribed, not avoided. Ask your doctor about vaccination, and mention heart failure to any clinician prescribing you an anti-inflammatory painkiller.

The signs of deterioration

Deterioration shows as a weight that climbs steadily, ankles or an abdomen that are more swollen, a need for extra pillows to sleep, breathlessness doing something that was comfortable last week, dizziness on standing, or a heart rhythm that has become fast and irregular.

Cardiomyopathy and myocarditis

Cardiomyopathy means disease of the heart muscle itself — the muscle is abnormal in structure or function for reasons that are not simply blocked arteries, a leaking valve or untreated high blood pressure. The distinction matters because these conditions are frequently inherited, they often present in younger people, they are diagnosed by imaging the muscle rather than the arteries, and they have implications for the whole family rather than one person.

The main types

• Dilated cardiomyopathy. The left ventricle enlarges and its walls thin, so contraction weakens. It usually presents as heart failure. Causes include inherited gene variants, previous viral infection, alcohol, some chemotherapy drugs, thyroid disease, iron overload, pregnancy, and a persistently fast heart rhythm — the last few mattering because removing the cause can allow real recovery of function.
• Hypertrophic cardiomyopathy. The muscle thickens abnormally, most often the septum between the ventricles, with no load to explain it. Discussed under hypertrophic cardiomyopathy.
• Restrictive cardiomyopathy. The muscle becomes stiff so the ventricle cannot fill, while its size and squeezing strength can look almost normal. It typically arises from something infiltrating the muscle — amyloid protein, sarcoidosis, iron in haemochromatosis — and identifying that process is the whole task.
• Arrhythmogenic cardiomyopathy. Heart muscle is progressively replaced by fat and fibrous tissue, classically in the right ventricle. It is inherited, it tends to present with palpitations, fainting or ventricular arrhythmia rather than breathlessness, and it is one of the few cardiac conditions in which intense endurance exercise appears to accelerate the disease. Restricting high-intensity exercise is part of the treatment, not a precaution.

Hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy is the commonest inherited heart condition. A gene variant, usually affecting a protein of the contractile machinery, causes the muscle to thicken. It is inherited in an autosomal dominant pattern, so each first-degree relative of an affected person has a one-in-two chance of carrying the same variant — which is why screening is offered to parents, siblings and children when a diagnosis is made. That family offer is one of the most valuable things the diagnosis produces.

Many people with HCM live a full life with few restrictions. Others have symptoms driven by obstruction of blood leaving the ventricle, by stiffness of the thickened muscle, or by arrhythmia: breathlessness on exertion, chest tightness, palpitations, light-headedness and fainting, characteristically during or straight after exertion and worse when dehydrated.

HCM is also the condition most associated with sudden cardiac death in young athletes, and that drives much of how it is managed. The risk of a dangerous rhythm is estimated formally, combining a validated risk calculator with features assessed individually: a family history of sudden death, unexplained fainting, extreme wall thickness, runs of fast ventricular rhythm on monitoring, and scarring on cardiac MRI. Where the estimated risk is high enough, an implantable defibrillator is discussed, with its own risks and long-term implications.

Treatment otherwise runs from medication upwards. Rate-slowing drug classes give the ventricle longer to fill and reduce obstruction; a newer class of cardiac myosin inhibitors acts directly on the overactive contraction and has changed what is possible for symptomatic obstruction; certain other drug groups are avoided because they worsen obstruction, which is why every prescriber needs to know the diagnosis. Where severe symptoms persist despite medication, septal reduction is considered — either alcohol septal ablation, delivered through a catheter into the small artery supplying the thickened septum so a controlled area of muscle shrinks, with a recognised chance of needing a permanent pacemaker afterwards because the conduction system runs through that territory; or surgical myectomy, in which the surgical team removes the excess muscle directly. Which suits you depends on your anatomy, your age and whether anything else needs operating on.

Myocarditis

Myocarditis is inflammation of the heart muscle, most commonly after a viral infection, and it differs from the cardiomyopathies in this section because most people recover. It causes some of the more alarming presentations in young adults: chest pain, breathlessness, palpitations or profound fatigue appearing days to a couple of weeks after a flu-like or gastrointestinal illness. Less common causes include autoimmune disease, certain cancer immunotherapies, and rare reactions to medicines and vaccines.

Diagnosis rests on the story plus a raised troponin, changes on the ECG, an echocardiogram, and above all cardiac MRI, which can show inflammation and oedema in the muscle and separate myocarditis from a heart attack when the arteries are clean (see technology). Coronary assessment is often still needed first, because the two present identically.

Most people recover fully, but recovery comes with a rule that people dislike and that exists for good reason: a defined period away from intense or competitive exercise, commonly around three to six months, because inflamed muscle is electrically unstable and exertion during that window is when dangerous rhythms occur. The length of that period, and the point at which you return, is decided by a cardiologist after repeat testing — not by how well you feel, which is the least reliable guide in this particular illness.

Cardiac amyloidosis

Cardiac amyloidosis deserves its own mention because it has moved in a few years from an obscure diagnosis to a recognised and treatable one, and because it is still frequently missed. Abnormal protein deposits in the heart muscle make it thick and stiff. The transthyretin form is found particularly in older men and is very often labelled instead as HFpEF or as thickening from high blood pressure.

The clues are worth knowing, because patients sometimes connect them before their doctors do: thickened heart walls on echocardiography with an ECG whose voltages are unexpectedly small, carpal tunnel syndrome in both hands years earlier, spinal canal stenosis, rupture of the biceps tendon, sudden intolerance of blood pressure medication in someone who used to need it, and a rise in troponin or BNP with no clear explanation. Diagnosis now relies on a nuclear bone-tracer scan performed with nuclear medicine, alongside blood and urine tests to exclude the light-chain form — a different disease, treated by haematology, that needs prompt recognition. Treatments that stabilise the abnormal protein now exist, so making the diagnosis has consequences.

Genetic testing, family screening and the limits of athlete screening

Genetic testing is offered where the result would change something: to confirm an otherwise uncertain diagnosis, to refine risk in specific conditions, and above all to allow cascade screening of relatives. When a causative variant is identified in one family member, relatives can be tested for that single variant, and those who do not carry it can be discharged from lifelong surveillance — often the most valuable outcome of the whole exercise. Counselling comes before testing, because the results carry implications for relatives who have not asked to know. Where no genetic cause is found, family screening is done clinically instead — examination, ECG and echocardiogram, usually beginning in adolescence and repeated periodically through the years in which these conditions typically declare themselves.

Screening athletes deserves an honest account. ECG-based programmes do detect some serious conditions before they cause harm, and that is a real benefit. But a normal ECG does not exclude everything: coronary artery anomalies, early arrhythmogenic cardiomyopathy and some channel disorders can all pass unnoticed. Screening also produces findings that turn out to be nothing, particularly in trained athletes whose hearts adapt in ways that mimic disease, and each of those costs weeks of investigation and sometimes an unnecessary period of restriction. The most reliable warnings remain the clinical ones, and they belong to the individual rather than the programme: fainting during exercise, chest pain on exertion, unexplained breathlessness out of proportion to training, palpitations during effort, and a family history of sudden unexplained death under the age of fifty. Any of those earns a proper cardiac assessment, whatever a screening ECG said.

Ejection fraction: what the number means and what it does not

Ejection fraction is the number most people take away from an echo report, and it is the number most often misread. It measures the proportion of the blood sitting in the left ventricle at the end of filling that is pushed out with the next beat. If the ventricle holds 100 millilitres when full and ejects 60 of them, the ejection fraction is 60%.

That definition is the whole point, and it is worth reading twice. Ejection fraction is not a mark out of a hundred. A healthy ventricle does not empty itself and is not built to. It refills between beats, and a reserve of blood left behind at the end of each contraction is normal physiology, not a failure. So a report saying 60% is not a heart working at three-fifths capacity, and it is not a school grade of D. It is a normal heart. A great many people spend a bad week on that misunderstanding before anyone explains it to them.

The number can be produced in several ways. Most often it comes from a transthoracic echocardiogram, either estimated visually by an experienced reader or calculated from traced outlines of the ventricle. It can also come from three-dimensional echo, from cardiac MRI, from a nuclear scan, from CT, or from contrast injected into the ventricle during a catheter study. These methods do not all give the same answer on the same heart on the same day, and none of them is wrong for that reason. They measure the same thing by different routes, with different assumptions about the shape of a chamber that is not a simple geometric solid.

The conventional bands used in reports are these:

• Normal: 50% and above. Most healthy adults land somewhere between the low fifties and the low seventies.
• Mildly reduced: 41 to 49%. Often the band that prompts a repeat study and a look for a cause rather than an immediate change of plan.
• Moderately reduced: 30 to 40%. Usually treated actively, whether or not you have symptoms.
• Severely reduced: below 30%. Treated actively, and the band in which rhythm protection and device options are formally considered.

Read those as measurement categories, not verdicts. A visual estimate carries genuine observer variation: two competent readers looking at the same loops can differ by several percentage points, and the same reader can differ from themselves on a different day. Image quality matters — a difficult scanning window in a larger chest or a patient with lung disease widens the uncertainty. Different methods carry different biases, and cardiac MRI generally reads a few points differently from echo on the same heart. The practical consequence is simple. A change of a few percentage points between two scans is often measurement noise rather than a change in your heart. A trend across several studies, measured the same way in the same laboratory, tells you far more than any single value. When you are comparing, compare like with like, and ask which method produced each number.

An ejection fraction well above the normal range is not automatically better, either. A ventricle that looks hyperdynamic can be a small, underfilled or thick-walled chamber emptying almost completely, which is itself a finding worth explaining rather than a sign of an unusually strong heart.

One question comes up more than any other: what a normal ejection fraction by age is. The honest answer disappoints it. Ejection fraction does not fall meaningfully with healthy ageing. Older hearts change in other measurable ways — the walls tend to stiffen, filling becomes slower, the left atrium often enlarges — but the fraction of blood ejected with each beat stays within the same normal range in an eighty-year-old as in a thirty-year-old. There is no age-adjusted table that makes a low number acceptable. If a value comes back reduced, the age on the request form is not the explanation, and treating it as one delays the search for a cause. Sex differences are small; women’s values sit marginally higher on average, not enough to change how any individual result is handled.

A reduced ejection fraction matters because of what it predicts and what it unlocks. It is the entry point to the assessment and treatment described in heart failure, where the cause is pursued — blocked arteries, a previous silent infarct, valve disease, uncontrolled blood pressure, a sustained fast rhythm, alcohol, chemotherapy, an inherited muscle disease, or inflammation of the muscle itself. Symptoms are an unreliable guide here. Some people with a markedly reduced ejection fraction feel almost normal, particularly if the decline was slow and they quietly reduced what they do. Feeling well is welcome, and it is not a reason to leave the number alone. Ejection fraction is also one input into whether an implantable defibrillator is discussed at all: the severely reduced band above is where rhythm protection is formally considered, alongside your diagnosis, your symptoms and how you have responded to several months of treatment. What such a device actually does is described under pacemakers and ICDs.

Here is the part that gets buried. Ejection fraction can improve. When the cause is treatable and treatment is given time — often several months of prescribed medicines, with rate or rhythm control if a fast arrhythmia was driving it, revascularisation where blood supply was the problem, or simply stopping alcohol — the ventricle can remodel and the number can rise, sometimes back into the normal range. This is why irreversible decisions are rarely made on a first low reading, and why a re-measurement after a defined period of optimised treatment is a standard part of the pathway rather than a delay. Improvement is not guaranteed and depends entirely on the cause, but a single low value is a starting point rather than a life sentence.

The final caution runs the other way. A normal ejection fraction does not exclude heart failure. A ventricle can squeeze normally and still fill poorly, generating high pressures, breathlessness and fluid retention with a perfectly respectable number on the report. That condition is heart failure with preserved ejection fraction, and it is one of the commonest reasons a breathless patient is told their echo is normal when it is not. Newer echo measures such as global longitudinal strain can pick up impaired muscle function while the ejection fraction still reads normal, which is why strain is used to monitor hearts during chemotherapy. If you are short of breath and your ejection fraction is normal, the question is not settled — it has only moved.

Cholesterol and lipids: reading the panel properly

A lipid panel is a handful of numbers printed on one line each, and almost everyone reads only the first one. What the standard panel reports is total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides, with non-HDL cholesterol either printed or trivially calculated from them. Cholesterol itself is not a poison; it is a structural molecule your body requires and manufactures. What matters is not its presence but how much of it is being carried into artery walls, in what, and for how long.

LDL cholesterol is the causal one. That is not an opinion drawn from one study type but the convergence of genetics, randomised trials and long-term observation: people who inherit lifelong low LDL levels have less coronary disease, and lowering LDL lowers events, by whatever mechanism it is lowered. The exposure is cumulative — it is the burden carried over decades, not the reading on one Tuesday morning, that builds plaque. This is why a moderately raised level at thirty-five is treated as more consequential than the same level first found at seventy-five.

HDL cholesterol was taught for years as “good cholesterol”, and that framing has aged badly. Low HDL reliably marks higher risk, but raising it with drugs did not reduce events in trials, and very high levels are not protective in the way the label implied. Treat HDL as a marker that adds context, not a target to chase. Triglycerides behave similarly: high levels usually signal an underlying metabolic problem — insulin resistance, excess alcohol, untreated diabetes, thyroid or kidney disease — and pursuing that cause is generally more productive than treating the number in isolation. Very high triglycerides carry a separate concern about the pancreas rather than the arteries.

The useful step beyond LDL alone is to stop counting cholesterol and start counting particles. Every atherogenic particle in your blood carries exactly one apolipoprotein B molecule on its surface. Measuring ApoB therefore counts the particles that can enter an artery wall, rather than measuring the cholesterol cargo those particles happen to be carrying. The distinction sounds academic until you meet discordance: two people with an identical LDL cholesterol can carry very different particle numbers, because one has fewer, larger, cholesterol-rich particles and the other has many small depleted ones. The second person has more chances of a particle lodging in a wall, and their LDL result understates their risk. That pattern is common in type 2 diabetes, metabolic syndrome and high triglycerides — exactly the people in whom a reassuring LDL is most likely to be wrong. Non-HDL cholesterol, which is simply total cholesterol minus HDL, captures the same idea with no extra test and no fasting requirement: it counts the cholesterol in every atherogenic particle rather than LDL alone.

Measure	What it actually counts	Why it is used
LDL cholesterol	Cholesterol carried inside LDL particles	The causal driver, and the measure most evidence and most treatment decisions are built on
Non-HDL cholesterol	Cholesterol in all atherogenic particles	Free with every panel, no fasting needed, better than LDL alone when triglycerides are high
ApoB	The number of atherogenic particles themselves	The most direct count of risk-carrying particles; exposes discordance a normal LDL would hide

On fasting: most guidelines now accept a non-fasting sample for a routine panel, and there is a reasonable argument that it better represents the state your blood spends most of its day in. Fasting is still asked for in specific situations — very high triglycerides, certain genetic assessments, or when a laboratory calculates LDL by a formula that a recent meal distorts. Follow the instruction on your request form rather than a general rule, and if nobody told you, ask before you skip breakfast unnecessarily.

Lipoprotein(a): the number almost nobody has measured

Lp(a) is an LDL-like particle with an additional protein wrapped around it, and it behaves as an independent driver of arterial disease and of calcific aortic valve disease. It has four properties that make it unlike anything else on the panel.

First, it is largely genetic. Your level is set overwhelmingly by inherited variation and stays broadly stable through adult life, which is why it explains the person with a bland lipid panel, no smoking history and an early heart attack, and why it clusters in families. Second, it usually only needs measuring once in a lifetime — there is no monitoring schedule, because there is nothing that meaningfully moves it. Third, and this is the part that surprises people, it is not lowered meaningfully by diet, exercise or statins. A perfect lifestyle will not bring it down, and neither will the drug most people are given for cholesterol. Fourth, a high level does not currently come with a treatment aimed at Lp(a) itself in routine practice, but it changes everything around it: it shifts an intermediate risk estimate upwards, it lowers the threshold for treating everything that is modifiable, it justifies looking harder at the coronary arteries, and it is a reason to check first-degree relatives.

One practical trap: Lp(a) is reported in either nmol/L or mg/dL, and the two scales are not interchangeable by any reliable conversion. When you compare a result across laboratories or countries, check the unit before you compare the number. And note that the value is not a diagnosis. It is a risk signal that reorganises a conversation, and the reorganising is done in a consultation, not by the reader.

Lipid treatment is discussed here by drug class only, because the choice, the dose and the monitoring belong to the doctor who knows your full picture. Statins remain the foundation and have the largest evidence base. Ezetimibe reduces absorption and is often added rather than substituted. PCSK9 inhibitors, given by injection, and newer agents acting on the same pathway are used where the target is not reached or statins genuinely cannot be tolerated. Availability, suitability and sequence vary by country, by insurer and by individual. Nothing in this section is a reason to start, stop, change or adjust any of them; that is prescribed and monitored by your own doctor.

Which brings us to statin side effects, a subject usually handled either dismissively or hysterically. Both are unhelpful. Muscle symptoms — aching, heaviness, weakness, most often in the thighs and shoulders — are by far the commonest complaint and the commonest reason people stop. Serious muscle injury exists but is rare. Liver enzyme changes are usually mild and monitored rather than dangerous. A small increase in the chance of being diagnosed with diabetes is real and is weighed against the cardiovascular benefit. At the same time, the nocebo effect here is genuine and unusually well documented: in blinded studies where people alternate between a statin and an identical placebo without knowing which they are taking, symptoms frequently appear on the placebo periods too. That finding does not mean your pain is imaginary. It means the pain may not be caused by the tablet, and the only way to find out is a structured re-challenge rather than a permanent assumption.

The productive response to side effects is a conversation with the prescriber about a lower dose, a different dosing schedule, a different statin, or a different class entirely. Many people who believe they cannot take any statin turn out to tolerate one of them at some dose. The unproductive response is silently stopping and telling nobody, which is common, invisible to your doctor, and removes the benefit while leaving the risk. Diet and weight remain part of every lipid plan whatever the prescription — see nutrition and diet for what actually changes these numbers and what does not. Targets are deliberately absent here, because the right target depends on your overall risk, and a number appropriate for one reader is wrong for the next. Ask what your target is, and why that one, in your own consultation.

Blood pressure: why the clinic reading is the worst one

High blood pressure is the most common reason a healthy adult is handed a diagnosis, and it is diagnosed on the least reliable data in medicine. The reading taken in a clinic is a single snapshot, captured after you hurried through traffic, sat in a waiting room, spoke to a stranger and rolled a sleeve over a jacket. It is one measurement of a value that changes minute to minute, all day, every day. It is not useless — it starts the conversation — but it should almost never end it.

One companion fact belongs beside every stubborn blood pressure: a meaningful minority of resistant hypertension has a findable hormonal driver, and the aldosterone work-up that finds it is described honestly by the endocrinology unit.

Two opposite errors follow from relying on it. White-coat hypertension is a reading that is high in the clinic and normal everywhere else; treating it as real leads to medicines the person did not need, and to side effects paying for a problem that does not exist. Masked hypertension is the mirror image — normal in the clinic, high at home or at work — and it is the more dangerous of the two, because the person is reassured and discharged while their arteries carry the load unopposed. Neither is rare. Neither can be detected without measuring outside the clinic.

That is what home measurement and 24-hour ambulatory blood pressure monitoring are for. The ambulatory monitor takes readings automatically through the day and, crucially, overnight; blood pressure that fails to dip during sleep is an independent signal worth knowing about, and no clinic visit can capture it. Home readings taken properly over a week or two carry more weight in a diagnosis than any single clinic reading, and they are the basis on which treatment is often started or, just as importantly, not started.

Home readings only help if the technique is right, and most home readings are not. Use a validated upper-arm device rather than a wrist or finger monitor, and:

• Get the cuff size right. A cuff too small for your arm reads falsely high, and this is the single commonest source of a wrong home number. Measure your upper arm circumference and match it to the manufacturer’s range.
• Sit properly. Back supported against the chair, feet flat on the floor, legs uncrossed. Crossed legs and an unsupported back both push the reading up.
• Keep the arm at heart level, resting on a table. An arm hanging down or held up changes the number by a clinically meaningful amount.
• Nothing beforehand. No caffeine, no smoking and no exercise in the half hour before, and empty your bladder first.
• Rest first. Sit quietly for about five minutes before the first reading, and do not talk or look at your phone during the measurement.
• Take two readings a minute or two apart and record both, not just the friendlier one. Bring the whole log, including the readings you dislike.
• Same times each day, typically morning before medication and evening, for the period your doctor asks for rather than indefinitely.

You will notice this section gives no threshold. That is deliberate, and it is not evasion. The number that counts as high genuinely differs between international guidelines, and the difference is a real disagreement among serious people rather than a mistake somebody should fix. The guidelines weigh the same evidence differently on where treatment benefit begins to outweigh its burden, and they build risk into the decision in different ways. So the threshold your doctor applies depends on which guideline their system follows and, far more importantly, on your overall cardiovascular risk: the same reading justifies treatment in one person and observation in another with the same number on the cuff. If you want to know where you stand, the question is not “what is the cut-off” but “what is my number, which guideline are you using, and what is my risk”.

Most high blood pressure has no single identifiable cause. A minority is secondary hypertension, driven by a specific and often treatable condition, and it is actively looked for when the pattern is unusual: onset at a young age, a sudden rise in someone previously well controlled, blood pressure that stays high despite several medicines taken properly, very high readings, or accompanying features such as low potassium on a blood test, episodes of sweating and palpitations, or loud snoring with daytime sleepiness. The usual suspects are primary aldosteronism — considerably more common than its reputation and frequently missed — kidney disease, narrowing of a renal artery, thyroid disorders, rarer adrenal tumours, obstructive sleep apnoea, and medicines or supplements including some anti-inflammatories, decongestants, steroids, liquorice and certain hormonal preparations. Hormonal causes are investigated with endocrinology, and the testing has to be organised carefully, because several common blood pressure medicines interfere with the results.

Lifestyle measures deserve an honest weighting rather than a list. Reducing sodium works, more in some people than others, and the effect for one individual is usually modest while the effect across a population is substantial; most dietary sodium comes from processed food and bread rather than the salt cellar. Alcohol has one of the most reliable dose-related effects on blood pressure of anything you control, and cutting back shows up on the cuff within weeks. Weight loss lowers blood pressure dependably. Regular aerobic exercise lowers it too, and there is growing evidence for isometric exercise specifically. Treating sleep apnoea helps where it is present. Potassium-rich diets help unless your kidneys mean they should not, which is a question for your doctor rather than a supplement aisle.

When medicines are needed, they come from a small number of well-established classes — ACE inhibitors, angiotensin receptor blockers, calcium channel blockers and thiazide-like diuretics, with others added for specific situations. Modern practice often favours low doses of two classes over a large dose of one, because the blood pressure effect is better and the side effects are fewer. All of it is prescribed and monitored by your own doctor, including the timing and any change, and none of it is adjusted on your own judgement or on a home reading you disliked.

A high reading on its own, with no symptoms, is not an emergency. What does need immediate action is a very high reading with signs that an organ is being damaged.

Prevention, screening and cardiac rehabilitation

Prevention in cardiology is usually presented as a calculator: enter age, sex, blood pressure, cholesterol and smoking status, receive a percentage. Risk scores are useful and they are worth doing, but the output is an average for people who resemble you on five or six variables, not a forecast for you. They know nothing about your family history, your Lp(a), your coronary calcium score, your inflammatory arthritis, your pregnancy history or your ethnic background — all of which move real risk without moving the score. Treat the estimate as the opening of a conversation about what to do, not as its conclusion. When the estimate sits in the intermediate zone, which is where most people land, additional information is exactly what breaks the tie.

The factors that genuinely move the needle are a short list: smoking, blood pressure, LDL and ApoB, diabetes and insulin resistance, weight and physical inactivity, and — through all of them — the number of years the exposure has lasted. The list people over-weight is longer: dietary cholesterol from eggs, coffee, occasional stress rather than sustained circumstances, single “superfoods”, detox regimes, routine fish oil and multivitamin supplements, and the belief that one recent normal test result closes the question for a decade. Attention spent on the second list is attention taken from the first.

Stopping smoking is the single highest-value intervention available to a person at cardiovascular risk. Nothing else you can do yourself produces the same magnitude of benefit, the excess risk begins to fall within the first year, and it keeps falling. Combining a stop-smoking programme with prescribed pharmacological support works far better than willpower alone, and relapse is part of the process rather than proof it cannot be done. The cardiovascular position on vaping is not fully settled; it is clearly not neutral, and it is not a destination.

Diabetes and insulin resistance are cardiovascular conditions that happen to be measured in glucose. Coronary disease in diabetes tends to be more diffuse and to present with fewer classic warning symptoms, which is one reason chest discomfort in a person with diabetes is taken seriously earlier. Managing glucose, blood pressure, lipids and weight together, with endocrinology where the metabolic picture is complex, does more than perfecting any one of them.

Exercise is worth prescribing in terms you can act on rather than slogans. The usual target is around 150 minutes a week of moderate activity — brisk enough that you can talk but not sing — or roughly half that if it is vigorous, plus muscle-strengthening work on two days a week. Two details matter more than the totals. The largest gain is at the bottom of the curve: moving from nothing to something small is worth more than moving from a lot to more. And breaking up long periods of sitting has value independent of your weekly total.

Obstructive sleep apnoea is the under-diagnosed cardiac risk factor. Repeated overnight drops in oxygen with surges of adrenaline drive blood pressure that resists treatment, make atrial fibrillation harder to keep away after treatment, and strain the right side of the heart. Loud snoring, breathing pauses witnessed by someone else, waking unrefreshed, and daytime sleepiness are the signals worth reporting; a sleep study is a straightforward test, and treating it changes cardiac outcomes rather than only sleep quality.

Cardiac rehabilitation is one of the most under-used treatments in cardiology, largely because the name sounds like a gym class. It is not. It is a supervised, structured programme combining exercise tailored to your tested capacity, education about your condition, medication review and risk-factor management, dietary advice, and psychological support for the anxiety and low mood that follow a cardiac event far more often than anyone admits. It is offered after a heart attack, after a stent, after cardiac surgery, to many people with stable angina or heart failure, and after some device implants. Where it is offered it is frequently declined by people who feel fine, or never mentioned to people who assume it is for someone frailer. If you have had an event and nobody has raised it, raise it yourself and ask what is available where you live, since programmes can be hospital-based, community-based or supervised remotely.

Screening healthy young athletes is a separate and genuinely contested question — whether to screen everyone with an ECG divides national programmes, and the honest account of what such screening does and does not catch, together with the warning symptoms that must never be trained through, is set out under genetic testing, family screening and the limits of athlete screening.

Women’s heart health

Coronary disease is the leading cause of death in women, and it is still under-recognised in them, by clinicians and by women themselves. Symptoms follow the same underlying mechanism but present differently often enough to matter: fatigue that is new and disproportionate, breathlessness, nausea, discomfort in the jaw, back or between the shoulder blades, and pressure that is described as heaviness rather than pain. These are not “atypical” so much as under-taught. Women also more often have disease of the small vessels or coronary spasm rather than a single blocked large artery, which means a normal angiogram can coexist with genuine ischaemia — the picture described in chest pain and angina. Spontaneous coronary artery dissection, which affects predominantly younger women without conventional risk factors, is another reason a young woman with chest pain is not automatically low risk.

Pregnancy is an unrepeatable cardiovascular stress test, and its results are recorded permanently. Pre-eclampsia, gestational hypertension, gestational diabetes, pre-term delivery and delivering a small-for-dates baby are all associated with higher lifelong cardiovascular risk, independent of what happens afterwards. Most risk calculators do not ask about them. You should volunteer them, in every cardiovascular consultation, however long ago they happened. Polycystic ovary syndrome and early menopause carry their own signals. The menopause transition itself brings unfavourable shifts in lipids, blood pressure and body composition, and palpitations during it are common and usually benign — but “usually” is decided after assessment, not before.

Family history earns its own attention. A first-degree relative with coronary disease at a young age, an unexplained sudden death, an inherited cardiomyopathy, or familial hypercholesterolaemia all change your baseline. Where a specific inherited condition is confirmed in a family, screening of first-degree relatives is offered systematically rather than opportunistically, working outwards from the affected person — clinical assessment, ECG and echo, with genetic testing where a causal variant has been identified. For familial hypercholesterolaemia, that cascade testing is one of the highest-yield screening activities in all of medicine, because the treatment is well established and the alternative is a first presentation with a heart attack.

Technology: what the equipment changes for you

Equipment lists are marketing. What is worth knowing is narrower and more useful: for each piece of technology, what does it change about the test you undergo, the radiation you receive, the certainty you leave with, and whether you need a second test at all. That is how the following is written.

Low-dose CT for calcium scoring matters because the whole value of the test depends on dose being trivially low. Modern scanners with iterative reconstruction and prospective gating acquire the images in a fraction of a second at a dose in the range of a mammogram, with no contrast injection and no cannula. That is what makes it defensible to scan an asymptomatic person to refine a risk estimate — the information is worth having only because the cost of getting it is so small. What the score means is in calcium score.

Coronary CT with FFR-CT changes something else: what happens after the scan. A CT can show a narrowing without telling you whether it actually restricts flow, which historically meant an invasive study to find out. Flow analysis derived computationally from the same CT dataset estimates the functional significance of the narrowing without a second test, a second dose or an arterial puncture. Fewer people go to the catheter lab to be told nothing needed doing. See CT coronary angiography.

Cardiac MRI deserves the most space, because it does something no other test does: it characterises the heart muscle itself rather than only its shape and motion. Echo shows you a wall that is thick or a chamber that is dilated. MRI can tell you why. Injected contrast that lingers in abnormal tissue produces patterns of late enhancement that are close to signatures — scar in the distribution of a coronary artery says there was an infarct, sometimes one nobody knew about; scar in the middle of the wall points away from coronary disease and towards an inherited or inflammatory cause; a diffuse pattern with abnormal tissue mapping raises amyloid; patchy enhancement with oedema on a matching sequence is the picture of myocarditis. Mapping sequences quantify swelling, fibrosis and iron loading without contrast at all. MRI also measures volumes and ejection fraction with the least operator dependence of any method, which is why it is used to settle disagreements between echoes and to make decisions that will not be revisited. Stress perfusion MRI assesses blood supply without radiation. The trade-offs are honest ones: the scan is long, requires repeated breath-holds and lying still, is unsuitable or unpleasant for some people with claustrophobia, needs planning around implanted devices even though most modern ones are MR-conditional, and gadolinium contrast requires attention to kidney function. When a diagnosis of cardiomyopathy or myocarditis is genuinely in question, this is usually the test that ends the argument.

Three-dimensional and transoesophageal echo change structural planning rather than diagnosis. Seeing a valve as a volume from the surgeon’s or the operator’s viewpoint, with precise measurements of the annulus and the leaflets, determines whether a device will fit and what size to bring into the room. Fusion of live echo with fluoroscopy during a procedure lets the operator watch soft tissue and hardware at the same time. This is what makes the catheter-based repairs in structural heart closures and mitral regurgitation plannable in advance rather than improvised.

Intravascular imaging and pressure wires change decisions inside the catheter lab. A contrast angiogram is a shadow of the lumen; ultrasound or optical imaging from inside the vessel shows the wall, the composition of the plaque, the true diameter and whether a deployed stent is fully expanded and apposed — the factors that determine whether it stays open. A pressure wire answers the question the picture cannot: is this narrowing actually limiting flow. Both reduce the number of stents placed where none were needed and improve the ones that are. See coronary angiography and stents.

Electroanatomic mapping changes what an ablation is. Building a three-dimensional electrical model of the chamber, with catheters tracked in space, lets the operator target the mechanism rather than search for it, records contact force so lesions are delivered properly, and — with newer energy sources that act on cardiac tissue selectively — reduces exposure to X-ray, sometimes to almost none. What that means for the procedure itself is in ablation.

Remote device monitoring changes follow-up. A pacemaker or defibrillator that transmits automatically reports arrhythmias, lead measurements and battery status between appointments, so problems surface as an alert rather than at the next clinic visit — useful for anyone, and considerably more useful for someone who lives in another country. See pacemakers and ICDs.

Now the argument this page is entitled to make, plainly. Equipment is necessary and it is not sufficient. Every capable centre buys from the same short list of manufacturers, and a photograph of a scanner tells you nothing about the person who will interpret it. What separates results in cardiology is not the machine but the team: how often this specific team performs this specific procedure, how well the interventionalist, the imaging specialist, the electrophysiologist, the anaesthetist and the nursing staff work as a unit, and what happens in the first hour when something goes wrong. Volume in a particular procedure is one of the more consistent predictors of how that procedure goes — not because busy operators are gifted, but because rare procedures have rare complications that only a practised team recognises early.

So the useful question is not “what scanner do you have”. It is: how often does this team do this exact procedure, who specifically will perform mine, and what is the plan if it does not go as expected. A centre that answers it comfortably and specifically is telling you more than any equipment list can.

Planning your care

Most cardiac second opinions are limited not by the reviewer but by what arrived. A cardiologist can only assess what they can see, and a summary written by someone else is not evidence — it is that person’s conclusion. If you are seeking a remote opinion, send the following.

• The actual imaging files, not the report. Ask your hospital’s imaging department for the DICOM data on a disc, a USB drive or a download link. A written report is a summary of what one person saw on one day. The images are the evidence.
• The ECG as an image of the trace — a photograph or scan of the whole 12-lead printout, not the one-line interpretation the machine printed at the top, which is frequently wrong. Send every ECG you have, including old normal ones, because comparison is often the entire diagnosis.
• Video where video exists. Echocardiography and angiography are moving studies; still frames lose most of the information. Ask specifically for the cine loops.
• Serial results with dates, in order — troponin values with the exact times they were taken, lipid panels across years, kidney function, HbA1c, thyroid function, and your home blood pressure log. A single value tells a reviewer far less than the same test repeated over time.
• A current medication list with doses, including the ones you were told to stop and when, plus allergies and any contrast reaction.
• Procedure and discharge documents: stent type, size and location; any device implant card with make and model; operation notes; and previous discharge summaries.

A remote review can do a great deal. It can say whether the working diagnosis fits the data, whether a proposed intervention is a reasonable reading of that data, whether an alternative approach exists, and — often the most valuable output — which single additional test would actually change the plan. It cannot examine you, cannot feel a pulse or hear a murmur, cannot know how breathless you become on your own stairs, and cannot read images that were never sent. It also cannot promise that the plan will hold once you are assessed in person, and any reviewer who promises that is telling you what you want to hear.

If you are travelling for treatment, expect the pathway to run in this order. You are assessed on arrival — history, examination, ECG, bloods and usually a repeat echo — before anything is confirmed. Repeat imaging genuinely does change plans, and that is not a sales manoeuvre: images degrade in transfer, studies age, and a severity grading made three months ago in a different laboratory may not be reproduced today. Sometimes the change is downwards, and the procedure discussed by email turns out not to be needed yet. Many catheter procedures are performed as a day case or with a single overnight stay, while others require inpatient care; which applies to you depends on the procedure, the access route discussed in coronary angiography and stents, and your other conditions. If the heart team’s assessment concludes that an open operation is the better option for your anatomy, that pathway is described under cardiovascular surgery.

Before you fly home, get the discharge instructions in writing, and do not accept a verbal answer for any of it. Ask specifically: when am I cleared to fly, and does that differ for this procedure; how do I care for the access site or wound and what does infection look like; when may I drive, lift, swim or return to work; exactly which medicines am I taking, at what dose, for how long, and who monitors them; what symptoms mean I return immediately and where do I go; what follow-up tests are due and when; and who do I or my local doctor contact with a question. Advice after a stent, an ablation and a device implant is different in each case and differs by individual — which is why it is written for you at discharge rather than invented on a web page. One point is not negotiable: if you are prescribed an antiplatelet or an anticoagulant, do not stop it on your own. Stopping an anticoagulant or antiplatelet without instruction is dangerous, and any pause for dental work, surgery or a procedure is planned in advance by the team that prescribed it.

Why this page publishes no prices, waiting times or outcome figures

This page gives no prices, no waiting times and no success or survival percentages, and the reason is that publishing them would mislead you rather than inform you. A price depends on which procedure you actually need after assessment, which is often not the one you arrived expecting, on the device used, on your length of stay and on what your insurer covers — so a headline figure would be wrong for almost everyone who read it. Waiting times change week to week and by procedure. Outcome percentages are the most misleading of the three: a published rate belongs to the particular population it was measured in, and centres that treat older, sicker or more complex patients report worse raw numbers while doing better work. Comparing two unadjusted percentages from two hospitals tells you about their patients, not about their skill. And no population figure is your figure — your risk depends on your anatomy, your kidneys, your other conditions and your age.

The useful version of all three questions is personal, and you are entitled to ask for it directly: ask for a written estimate for your specific plan, the current timeframe for your specific procedure, and the risks and expected results for someone with your findings, from the team that has actually reviewed your images. That answer is worth something. A number on a marketing page is not.